MolBio_Sp04_pres_08
cas638132-34-0_ONO-7300243_MedBio使用方法
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED13195
L-365,260
L-365,260
118101-09-0
50mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED13205
Atipamezole hydrochloride
Atipamezole hydrochloride
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED13078
Mesulergine hydrochloride
Mesulergine hydrochloride
72786-12-0
50mg
≥98%
Kinetensin (human)
103131-69-7
1mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED12631
Montelukast Sodium
Montelukast Sodium
151767-02-1
10mM (in 1mL DMSO)
≥98%
品牌
货号
中文名称
英文名称
104075-48-1
10mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED12896
DV 7028 hydrochloride
欧洲药典8.0 buffer solutions
4.1.3.Buffer solutions EUROPEAN PHARMACOPOEIA8.0Sulfite standard solution (1.5ppm SO 2).5002900.Dissolve sodium metabisulfite R equivalent to 0.152g of Na 2S 2O 5in water R and dilute to 100.0mL with the same solvent.Dilute 5.0mL of this solution to 100.0mL with water R .To 3.0mL of the resulting solution,add 4.0mL of 0.1M sodium hydroxide and dilute to 100.0mL with water R .Thallium standard solution (10ppm Tl).5003000.Dissolve thallous sulfate R equivalent to 0.1235g of Tl 2SO 4in a 9g/L solution of sodium chloride R and dilute to 1000.0mL with the same solution.Dilute 10.0mL of the solution to 100.0mL with the 9g/L solution of sodium chloride R .Tin liposoluble standard solution (1000ppm Sn).5005000.A tin (metal)organic compound in an oil.Tin standard solution (5ppm Sn).5003100.Dissolve tin R equivalent to 0.500g of Sn in a mixture of 5mL of water R and 25mL of hydrochloric acid R and dilute to1000.0mL with water R .Dilute the solution to 100times itsvolume with a 2.5per cent V/V solution of hydrochloric acid R immediately before use.Tin standard solution (0.1ppm Sn).5003101.Immediately before use,dilute tin standard solution (5ppmSn)R to 50times its volume with water R .Titanium standard solution (100ppm Ti).5003200.Dissolve 100.0mg of titanium R in 100mL of hydrochloricacid R diluted to 150mL with water R ,heating if necessary.Allow to cool and dilute to 1000mL with water R .Vanadium standard solution (1g/L V).5003300.Dissolve in water R ammonium vanadate R equivalent to0.230g of NH 4VO 3and dilute to 100.0mL with the samesolvent.Zinc standard solution (5mg/mL Zn).5003400.Dissolve 3.15g of zinc oxide R in 15mL of hydrochloric acid Rand dilute to 500.0mL with water R .Zinc standard solution (100ppm Zn).5003401.Immediately before use,dilute with water R to 10times its volume a solution containing zinc sulfate R equivalent to0.440g of ZnSO 4,7H 2O and 1mL of acetic acid R in 100.0mL.Zinc standard solution (10ppm Zn).5003402.Immediately before use,dilute zinc standard solution (100ppm Zn)R to 10times its volume with water R .Zinc standard solution (5ppm Zn).5003403.Immediately before use,dilute zinc standard solution (100ppm Zn)R to 20times its volume with water R .Zirconium standard solution (1g/L Zr).5003500.Dissolve zirconyl nitrate R equivalent to 0.293g ofZrO(NO 3)2,2H 2O in a mixture of 2volumes of hydrochloric acid R and 8volumes of water R and dilute to 100.0mL with the same mixture of solvents.01/2014:401034.1.3.BUFFER SOLUTIONSBuffered acetone solution.4000100.Dissolve 8.15g of sodium acetate R and 42g of sodium chloride R in water R ,add 68mL of 0.1M hydrochloric acid and 150mL of acetone R and dilute to 500mL with water R .Buffer solution pH 2.0.4000200.Dissolve 6.57g of potassium chloride R in water R and add 119.0mL of 0.1M hydrochloric acid .Dilute to 1000.0mL with water R .Phosphate buffer solution pH 2.0.4007900.Dissolve 8.95g of disodium hydrogen phosphate R and 3.40g of potassium dihydrogen phosphate R in water R and dilute to 1000.0mL with the same solvent.If necessary adjust the pH with phosphoric acid R .Sulfate buffer solution pH 2.0.4008900.Dissolve 132.1g of ammonium sulfate R in water R and dilute to 500.0mL with the same solvent (Solution A).Carefully and with constant cooling stir 14mL of sulfuric acid R into about 400mL of water R ;allow to cool and dilute to 500.0mL with water R (Solution B).Mix equal volumes of solutions A and B.Adjust the pH if necessary.Buffer solution pH 2.2.4010500.Mix 6.7mL of phosphoric acid R with 55.0mL of a 40g/Lsolution of sodium hydroxide R and dilute to 1000.0mL with water R .Buffer solution pH 2.5.4000300.Dissolve 100g of potassium dihydrogen phosphate R in 800mL of water R ;adjust to pH 2.5with hydrochloric acid R anddilute to 1000.0mL with water R .Buffer solution pH 2.5R1.4000400.To 4.9g of dilute phosphoric acid R add 250mL of water R .Adjust the pH with dilute sodium hydroxide solution R anddilute to 500.0mL with water R .0.2M Phosphate buffer solution pH 2.5.4014100.Dissolve 27.2g of potassium dihydrogen phosphate R in about900mL of water R ,adjust to pH 2.5with phosphoric acid Rand dilute to 1.0L with water R .Phosphate buffer solution pH 2.8.4010600.Dissolve 7.8g of sodium dihydrogen phosphate R in 900mL ofwater R ,adjust to pH 2.8with phosphoric acid R and dilute to1000mL with the same solvent.Buffer solution pH 3.0.4008000.Dissolve 21.0g of citric acid R in 200mL of 1M sodiumhydroxide and dilute to 1000mL with water R .Dilute 40.3mL of this solution to 100.0mL with 0.1M hydrochloric acid .0.25M Citrate buffer solution pH 3.0.4012600.Dissolve 5.3g of citric acid R in 80mL of water R .Adjust thepH with 1M sodium hydroxide and dilute to 100.0mL with water R .0.1M Phosphate buffer solution pH 3.0.4011500.Dissolve 12.0g of anhydrous sodium dihydrogen phosphate R in water R ,adjust the pH with dilute phosphoric acid R1and dilute to 1000mL with water R .Phosphate buffer solution pH 3.0.4000500.Mix 0.7mL of phosphoric acid R with 100mL of water R .Dilute to 900mL with the same solvent.Adjust to pH 3.0with strong sodium hydroxide solution R and dilute to 1000mL with water R .Phosphate buffer solution pH 3.0R1.4010000.Dissolve 3.40g of potassium dihydrogen phosphate R in900mL of water R .Adjust to pH 3.0with phosphoric acid R and dilute to 1000.0mL with water R .Phosphate buffer solution pH 3.2.4008100.To 900mL of a 4g/L solution of sodium dihydrogenphosphate R ,add 100mL of a 2.5g/L solution of phosphoric acid R .Adjust the pH if necessary.Phosphate buffer solution pH 3.2R1.4008500.Adjust a 35.8g/L solution of disodium hydrogen phosphate R to pH 3.2with dilute phosphoric acid R .Dilute 100.0mL of the solution to 2000.0mL with water R .EUROPEAN PHARMACOPOEIA 8.0 4.1.3.BuffersolutionsBuffer solution pH 3.5.4000600.Dissolve 25.0g of ammonium acetate R in 25mL of water R and add 38.0mL of hydrochloric acid R1.Adjust the pH if necessary with dilute hydrochloric acid R or dilute ammonia R1.Dilute to 100.0mL with water R .Phosphate buffer solution pH 3.5.4000700.Dissolve 68.0g of potassium dihydrogen phosphate R in water R and dilute to 1000.0mL with the same solvent.Adjustthe pH with phosphoric acid R .Buffer solution pH 3.6.4000800.To 250.0mL of 0.2M potassium hydrogen phthalate R add11.94mL of 0.2M hydrochloric acid .Dilute to 1000.0mLwith water R .Buffer solution pH 3.7.4000900.To 15.0mL of acetic acid R add 60mL of ethanol (96percent)R and 20mL of water R .Adjust to pH 3.7by the addition of ammonia R .Dilute to 100.0mL with water R .Buffered copper sulfate solution pH 4.0.4001000.Dissolve 0.25g of copper sulfate R and 4.5g of ammonium acetate R in dilute acetic acid R and dilute to 100.0mL with the same solvent.0.1M Sodium acetate buffer solution pH 4.0.4013800.Dissolve 822mg of sodium acetate R in 100mL of water R (solution A).Dilute 1.44mL of glacial acetic acid R in 250mL of water R (solution B).Titrate 100mL of solution B using about 20mL of solution A.Acetate buffer solution pH 4.4.4001100.Dissolve 136g of sodium acetate R and 77g of ammonium acetate R in water R and dilute to 1000.0mL with the same solvent;add 250.0mL of glacial acetic acid R and mix.Phthalate buffer solution pH 4.4.4001200.Dissolve 2.042g of potassium hydrogen phthalate R in 50mL of water R ,add 7.5mL of 0.2M sodium hydroxide and dilute to 200.0mL with water R .Acetate buffer solution pH 4.5.4012500.Dissolve 77.1g of ammonium acetate R in water R .Add 70mL of glacial acetic acid R and dilute to 1000.0mL with water R .0.5M Ammonium acetate buffer solution pH 4.5.4014200.Mix 14.3mL of glacial acetic acid R and 470mL of water Rand adjust to pH 4.5with concentrated ammonia R .Dilute to 500.0mL with water R .0.05M Phosphate buffer solution pH 4.5.4009000.Dissolve 6.80g of potassium dihydrogen phosphate R in1000.0mL of water R .The pH of the solution is 4.5.Sodium acetate buffer solution pH 4.5.4010100.Dissolve 63g of anhydrous sodium acetate R in water R ,add 90mL acetic acid R and adjust to pH 4.5,and dilute to1000mL with water R .Acetate buffer solution pH 4.6.4001400.Dissolve 5.4g of sodium acetate R in 50mL of water R ,add2.4g of glacial acetic acid R and dilute to 100.0mL withwater R .Adjust the pH if necessary.Succinate buffer solution pH 4.6.4001500.Disssolve 11.8g of succinic acid R in a mixture of 600mL ofwater R and 82mL of 1M sodium hydroxide and dilute to1000.0mL with water R .Acetate buffer solution pH 4.7.4001600.Dissolve 136.1g of sodium acetate R in 500mL of water R .Mix 250mL of this solution with 250mL of dilute acetic acid R .Shake twice with a freshly prepared,filtered,0.1g/L solution of dithizone R in chloroform R .Shake with carbon tetrachloride R until the extract is colourless.Filter the aqueous layer to remove traces of carbon tetrachloride.Acetate buffer solution pH 4.7R1.4013600.Dissolve 136.1g of sodium acetate R in 500mL of water R .Mix 250mL of this solution with 250mL of dilute acetic acid R .Acetate buffer solution pH 5.0.4009100.To 120mL of a 6g/L solution of glacial acetic acid R add 100mL of 0.1M potassium hydroxide and about 250mL ofwater R .Mix.Adjust the pH to 5.0with a 6g/L solution ofacetic acid R or with 0.1M potassium hydroxide and dilute to 1000.0mL with water R .Citrate buffer solution pH 5.0.4010700.Prepare a solution containing 20.1g/L of citric acid R and 8.0g/L of sodium hydroxide R .Adjust the pH with dilute hydrochloric acid R .0.2M Deuterated sodium phosphate buffer solution pH 5.0.4013900.Dissolve 2.76g of sodium dihydrogen phosphate monohydrate R in 90mL of deuterium oxide R ,adjust the pH with a deuterated solution of phosphoric acid R or a deuterated 1M solution of sodium hydroxide R ,dilute to 100mL with deuterium oxide R and mix.Phosphate buffer solution pH 5.0.4011300.Dissolve 2.72g of potassium dihydrogen phosphate R in 800mL of water R .Adjust the pH with 1M potassium hydroxide and dilute to 1000mL with water R .Buffer solution pH 5.2.4001700.Dissolve 1.02g of potassium hydrogen phthalate R in 30.0mL of 0.1M sodium hydroxide .Dilute to 100.0mL with water R .0.067M Phosphate buffer solution pH 5.4.4012000.Mix appropriate volumes of a 23.99g/L solution of disodium hydrogen phosphate R with a 9.12g/L solution of sodium dihydrogen phosphate monohydrate R to obtain pH 5.4.Acetate-edetate buffer solution pH 5.5.4001900.Dissolve 250g of ammonium acetate R and 15g sodiumedetate R in 400mL of water R and add 125mL of glacial acetic acid R .Buffer solution pH 5.5.4001800.Dissolve 54.4g of sodium acetate R in 50mL of water R ,heating to 35°C if necessary.After cooling,slowly add 10mL of anhydrous acetic acid R .Shake and dilute to 100.0mL withwater R .Phosphate buffer solution pH 5.5.4002000.Dissolve 13.61g of potassium dihydrogen phosphate R inwater R and dilute to 1000.0mL with the same solvent(solution A).Dissolve 35.81g of disodium hydrogen phosphate R in water R and dilute to 1000.0mL with the same solvent (solution B).Mix 96.4mL of solution A and 3.6mL of solution B.Phosphate-citrate buffer solution pH 5.5.4008700.Mix 56.85mL of a 28.4g/L solution of anhydrous disodium hydrogen phosphate R and 43.15mL of a 21g/L solution of citric acid R .Phosphate buffer solution pH 5.6.4011200.Dissolve 0.908g of potassium dihydrogen phosphate R in water R and dilute to 100.0mL with the same solvent (solution A).Dissolve 1.161g of dipotassium hydrogenphosphate R in water R and dilute to 100.0mL with the same solvent (solution B).Mix 94.4mL of solution A and 5.6mL of solution B.If necessary,adjust to pH 5.6using solution A or solution B.4.1.3.Buffer solutions EUROPEAN PHARMACOPOEIA8.0Phosphate buffer solution pH5.8.4002100.Dissolve1.19g of disodium hydrogen phosphate dihydrate R and8.25g of potassium dihydrogen phosphate R in water R and dilute to1000.0mL with the same solvent.Acetate buffer solution pH6.0.4002200.Dissolve100g of ammonium acetate R in300mL of water R, add4.1mL of glacial acetic acid R,adjust the pH if necessary using ammonia R or acetic acid R and dilute to500.0mL with water R.Diethylammonium phosphate buffer solution pH6.0. 4002300.Dilute68mL of phosphoric acid R to500mL with water R. To25mL of this solution add450mL of water R and6mLof diethylamine R,adjust to pH6±0.05,if necessary,using diethylamine R or phosphoric acid R and dilute to500.0mL with water R.Phosphate buffer solution pH6.0.4002400.Mix63.2mL of a71.5g/L solution of disodium hydrogen phosphate R and36.8mL of a21g/L solution of citric acid R. Phosphate buffer solution pH6.0R1.4002500.Dissolve6.8g of sodium dihydrogen phosphate R in water R and dilute to1000.0mL with water R.Adjust the pH with strong sodium hydroxide solution R.Phosphate buffer solution pH6.0R2.4002600.To250.0mL of0.2M potassium dihydrogen phosphate R add 28.5mL of0.2M sodium hydroxide and dilute to1000.0mL with water R.Phosphate buffer solution pH6.4.4002800.Dissolve2.5g of disodium hydrogen phosphate R,2.5g of sodium dihydrogen phosphate R and8.2g of sodium chloride R in950mL of water R.Adjust the pH of the solution to6.4with 1M sodium hydroxide or1M hydrochloric acid,if necessary. Dilute to1000.0mL with water R.0.5M Phthalate buffer solution pH6.4.4009200. Dissolve100g of potassium hydrogen phthalate R in water R and dilute to1000.0mL with the same solvent.Adjust the pH if necessary,using strong sodium hydroxide solution R. Buffer solution pH6.5.4002900.Dissolve60.5g of disodium hydrogen phosphate R and46g of potassium dihydrogen phosphate R in water R.Add100mL of 0.02M sodium edetate and20mg of mercuric chloride R and dilute to1000.0mL with water R.Imidazole buffer solution pH6.5.4003000.Dissolve6.81g of imidazole R,1.23g of magnesium sulfate R and0.73g of calcium sulfate R in752mL of0.1M hydrochloric acid.Adjust the pH if necessary and dilute to1000.0mL with water R.0.1M phosphate buffer solution pH6.5.4010800. Dissolve13.80g of sodium dihydrogen phosphate monohydrate R in900mL of distilled water R.Adjust the pH using a400g/L solution of sodium hydroxide R.Dilute to 1000mL with distilled water R.Phosphate buffer solution pH6.5.4012800.Dissolve2.75g of sodium dihydrogen phosphate R and4.5g of sodium chloride R in500mL of water R.Adjust the pH with phosphate buffer solution pH8.5R.Buffer solution pH6.6.4003100.To250.0mL of0.2M potassium dihydrogen phosphate R add 89.0mL of0.2M sodium hydroxide.Dilute to1000.0mL with water R.0.1M Phosphate buffer solution pH6.7.4014300. Dissolve15.6g of sodium dihydrogen phosphate R in water R and dilute to1.0L with the same solvent.Dissolve17.8g of disodium hydrogen phosphate dihydrate R in water R and dilute to1.0L with the same solvent.Mix the solutions,check the pH and if necessary adjust to pH6.7.Phosphate buffered saline pH6.8.4003200.Dissolve1.0g of potassium dihydrogen phosphate R,2.0gof dipotassium hydrogen phosphate R and8.5g of sodium chloride R in900mL of water R,adjust the pH if necessary and dilute to1000.0mL with the same solvent. Phosphate buffer solution pH6.8.4003300.Mix77.3mL of a71.5g/L solution of disodium hydrogen phosphate R with22.7mL of a21g/L solution of citric acid R. Phosphate buffer solution pH6.8R1.4003400.To51.0mL of a27.2g/L solution of potassium dihydrogen phosphate R add49.0mL of a71.6g/L solution of disodium hydrogen phosphate R.Adjust the pH if necessary. Storage:at2°C to8°C.1M tris-hydrochloride buffer solution pH6.8.4009300. Dissolve60.6g of tris(hydroxymethyl)aminomethane R in 400mL of water R.Adjust the pH with hydrochloric acid R and dilute to500.0mL with water R.Buffer solution pH7.0.4003500.To1000mL of a solution containing18g/L of disodium hydrogen phosphate R and23g/L of sodium chloride R add sufficient(about280mL)of a solution containing7.8g/Lof sodium dihydrogen phosphate R and23g/L of sodium chloride R to adjust the pH.Dissolve in the solution sufficient sodium azide R to give a0.2g/L solution.Maleate buffer solution pH7.0.4003600.Dissolve10.0g of sodium chloride R,6.06g oftris(hydroxymethyl)aminomethane R and4.90g of maleic anhydride R in900mL of water R.Adjust the pH using a 170g/L solution of sodium hydroxide R.Dilute to1000.0mL with water R.Storage:at2°C to8°C;use within3days.0.025M Phosphate buffer solution pH7.0.4009400.Mix1volume of0.063M phosphate buffer solution pH7.0R with1.5volumes of water R.0.03M Phosphate buffer solution pH7.0.4010300. Dissolve5.2g of dipotassium hydrogen phosphate R in900mL of water for chromatography R.Adjust the solution to pH7.0±0.1using phosphoric acid R and dilute to1000mL with water for chromatography R.0.05M Phosphate buffer solution pH7.0.4012400.Mix34mL of water R and100mL of0.067M phosphate buffer solution pH7.0R.0.063M Phosphate buffer solution pH7.0.4009500. Dissolve5.18g of anhydrous disodium hydrogen phosphate R and3.65g of sodium dihydrogen phosphate monohydrate R in 950mL of water R and adjust the pH with phosphoric acid R; dilute to1000.0mL with water R.0.067M Phosphate buffer solution pH7.0.4003800. Dissolve0.908g of potassium dihydrogen phosphate Rin water R and dilute to100.0mL with the same solvent (solution A).Dissolve2.38g of disodium hydrogen phosphate R in water R and dilute to100.0mL with the same solvent (solution B).Mix38.9mL of solution A and61.1mL of solution B.Adjust the pH if necessary.EUROPEAN PHARMACOPOEIA 8.0 4.1.3.Buffersolutions0.1M Phosphate buffer solution pH 7.0.4008200.Dissolve 1.361g of potassium dihydrogen phosphate R in water R and dilute to 100.0mL with the same solvent.Adjust the pH using a 35g/L solution of disodium hydrogen phosphate R .Phosphate buffer solution pH 7.0.4003700.Mix 82.4mL of a 71.5g/L solution of disodium hydrogen phosphate R with 17.6mL of a 21g/L solution of citric acid R .Phosphate buffer solution pH 7.0R1.4003900.Mix 250.0mL of 0.2M potassium dihydrogen phosphate R and 148.2mL of a 8g/L solution of sodium hydroxide R ,adjust the pH if necessary.Dilute to 1000.0mL with water R .Phosphate buffer solution pH 7.0R2.4004000.Mix 50.0mL of a 136g/L solution of potassium dihydrogenphosphate R with 29.5mL of 1M sodium hydroxide and dilute to 100.0mL with water R .Adjust the pH to 7.0±0.1.Phosphate buffer solution pH 7.0R3.4008600.Dissolve 5g of potassium dihydrogen phosphate R and 11gof dipotassium hydrogen phosphate R in 900mL of water R .Adjust to pH 7.0with dilute phosphoric acid R or dilute sodium hydroxide solution R .Dilute to 1000mL with water R and mix.Phosphate buffer solution pH 7.0R4.4010200.Dissolve 28.4g of anhydrous disodium hydrogen phosphate R and 18.2g of potassium dihydrogen phosphate R in water R and dilute to 500mL with the same solvent.Phosphate buffer solution pH 7.0R5.4011400.Dissolve 28.4g of anhydrous disodium hydrogen phosphate R in 800mL of water R .Adjust the pH using a 30per cent m/m solution of phosphoric acid R and dilute to 1000mL with water R .Tetrabutylammonium buffer solution pH 7.0.4010900.Dissolve 6.16g of ammonium acetate R in a mixture of 15mL of tetrabutylammonium hydroxide solution (400g/L)R and 185mL of water R .Adjust the pH with nitric acid R .Buffered salt solution pH 7.2.4004300.Dissolve in water R 8.0g of sodium chloride R ,0.2g of potassium chloride R ,0.1g of anhydrous calcium chloride R ,0.1g of magnesium chloride R ,3.18g of disodium hydrogen phosphate R and 0.2g of potassium dihydrogen phosphate R and dilute to 1000.0mL with water R .Buffer solution pH 7.2.4004100.To 250.0mL of 0.2M potassium dihydrogen phosphate R add 175.0mL of 0.2M sodium hydroxide .Dilute to 1000.0mL with water R .Adjust the pH if necessary.Phosphate-albumin buffered saline pH 7.2.4004400.Dissolve 10.75g of disodium hydrogen phosphate R ,7.6g of sodium chloride R and 10g of bovine albumin R in water R and dilute to 1000.0mL with the same solvent.Immediately before use adjust the pH using dilute sodium hydroxide solution R or dilute phosphoric acid R .Phosphate-albumin buffered saline pH 7.2R1.4009600.Dissolve 10.75g of disodium hydrogen phosphate R ,7.6g of sodium chloride R and 1g of bovine albumin R in water R and dilute to 1000.0mL with the same solvent.Immediately before use adjust the pH using dilute sodium hydroxide solution Ror dilute phosphoric acid R .Phosphate buffer solution pH 7.2.4004200.Mix 87.0mL of a 71.5g/L solution of disodium hydrogenphosphate R with 13.0mL of a 21g/L solution of citric acid R .Imidazole buffer solution pH 7.3.4004500.Dissolve 3.4g of imidazole R and 5.8g of sodium chloride R in water R ,add 18.6mL of 1M hydrochloric acid and dilute to 1000.0mL with water R .Adjust the pH if necessary.Barbital buffer solution pH 7.4.4004700.Mix 50mL of a solution in water R containing 19.44g/L of sodium acetate R and 29.46g/L of barbital sodium R with 50.5mL of 0.1M hydrochloric acid ,add 20mL of an 85g/L of sodium chloride R and dilute to 250mL with water R .Buffer solution pH 7.4.4004600.Dissolve 0.6g of potassium dihydrogen phosphate R ,6.4g of disodium hydrogen phosphate R and 5.85g of sodium chloride R in water R ,and dilute to 1000.0mL with the same solvent.Adjust the pH if necessary.Phosphate buffered saline pH 7.4.4005000.Dissolve 2.38g of disodium hydrogen phosphate R ,0.19g of potassium dihydrogen phosphate R and 8.0g of sodiumchloride R in water.Dilute to 1000.0mL with the same solvent.Adjust the pH if necessary.Phosphate buffer solution pH 7.4.4004800.Add 250.0mL of 0.2M potassium dihydrogen phosphate R to 393.4mL of 0.1M sodium hydroxide .Tris(hydroxymethyl)aminomethane buffer solution pH 7.4.4012100.Dissolve 30.3g of tris(hydroxymethyl)aminomethane R in approximately 200mL of water R .Add 183mL of 1M hydrochloric acid .Dilute to 500.0mL with water R .Note:the pH is 7.7-7.8at room temperature and 7.4at 37°C.This solution is stable for several months at 4°C.Tris(hydroxymethyl)aminomethane sodium chloride buffer solution pH 7.4.4004900.Dissolve 6.08g of tris(hydroxymethyl)aminomethane R ,8.77g of sodium chloride R in 500mL of distilled water R .Add 10.0g of bovine albumin R .Adjust the pH using hydrochloric acid R .Dilute to 1000.0mL with distilled water R .Tris(hydroxymethyl)aminomethane sodium chloride buffer solution pH 7.4R1.4012200.Dissolve 0.1g of bovine albumin R in a mixture containing 2mL of tris(hydroxymethyl)aminomethane buffer solution pH 7.4R and 50mL of a 5.84mg/mL solution of sodium chloride R .Dilute to 100.0mL with water R .Tris-sodium acetate buffer solution pH 7.4.4012900.Dissolve 6.3g of tris(hydroxymethyl)aminomethane R and 4.9g of anhydrous sodium acetate R in 900mL of water R .Adjust to pH 7.4with sulfuric acid R and dilute to 1000mL with water R .Tris-sodium acetate-sodium chloride buffer solution pH 7.4.4013000.Dissolve 30.0g of tris(hydroxymethyl)aminomethane R ,14.5gof anhydrous sodium acetate R and 14.6g of sodium chloride R in 900mL of water R .Add 0.50g of bovine albumin R .Adjust to pH 7.4with sulfuric acid R and dilute to 1000mL with water R .Borate buffer solution pH 7.5.4005200.Dissolve 2.5g of sodium chloride R ,2.85g of disodium tetraborate R and 10.5g of boric acid R in water R and dilute to 1000.0mL with the same solvent.Adjust the pH if necessary.Storage :at 2°C to 8°C.Buffer (HEPES)solution pH 7.5.4009700.Dissolve 2.38g of 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid R in about 90mL of water R .Adjust thepH to 7.5with sodium hydroxide solution R .Dilute to 100mL with water R .4.1.3.Buffer solutions EUROPEAN PHARMACOPOEIA8.00.05M Phosphate buffer solution pH7.5.4014400. Dissolve0.89g of disodium hydrogen phosphate dihydrate R in about80mL of water R.Adjust to pH7.5with an8.5per cent V/V solution of phosphoric acid R and dilute to100.0mL with water R.0.2M Phosphate buffer solution pH7.5.4005400. Dissolve27.22g of potassium dihydrogen phosphate R in930mL of water R,adjust to pH7.5with a300g/L solution of potassium hydroxide R and dilute to1000.0mL with water R.0.33M Phosphate buffer solution pH7.5.4005300. Dissolve119.31g of disodium hydrogen phosphate R in water R and dilute to1000.0mL with the same solvent(solution A). Dissolve45.36g of potassium dihydrogen phosphate R in water R and dilute to1000.0mL with the same solvent (solution B).Mix85mL of solution A and15mL of solution B. Adjust the pH if necessary.0.05M Tris-hydrochloride buffer solution pH7.5.4005600. Dissolve6.057g of tris(hydroxymethyl)aminomethane R in water R and adjust the pH with hydrochloric acid R.Dilute to 1000.0mL with water R.1M Tris-hydrochloride buffer solution pH7.5.4014500. Dissolve12.11g of tris(hydroxymethyl)aminomethane R in 90mL of water R,adjust to pH7.5with hydrochloric acid R and dilute to100.0mL with water R.Tris(hydroxymethyl)aminomethane buffer solution pH7.5. 4005500.Dissolve7.27g of tris(hydroxymethyl)aminomethane R and 5.27g of sodium chloride R in water R,and adjust the pH if necessary.Dilute to1000.0mL with water R.Sodium citrate buffer solution pH7.8(0.034M sodium citrate,0.101M sodium chloride).4009800.Dissolve10.0g of sodium citrate R and5.90g of sodium chloride R in900mL of water R.Adjust the pH by addition of hydrochloric acid R and dilute to1000mL with water R.0.0015M Borate buffer solution pH8.0.4006000. Dissolve0.572g of disodium tetraborate R and2.94g of calcium chloride R in800mL of water R.Adjust the pH with 1M hydrochloric acid.Dilute to1000.0mL with water R. Buffer solution pH8.0.4005900.To50.0mL of0.2M potassium dihydrogen phosphate R add 46.8mL of0.2M sodium hydroxide.Dilute to200.0mL with water R.Buffer solution pH8.0R1.4010400.Dissolve20g of dipotassium hydrogen phosphate R in900mL of water R.Adjust the pH with phosphoric acid R.Dilute to 1000mL with water R.0.02M Phosphate buffer solution pH8.0.4006100.To50.0mL of0.2M potassium dihydrogen phosphate R add 46.8mL of0.2M sodium hydroxide.Dilute to500.0mL with water R.0.02M Sodium phosphate buffer solution pH8.0.4013700. Dissolve0.31g of sodium dihydrogen phosphate R in70mL of water R and adjust to pH8.0with1M sodium hydroxide,then dilute to100mL with water R.0.1M Phosphate buffer solution pH8.0.4008400. Dissolve0.523g of potassium dihydrogen phosphate R and 16.73g of dipotassium hydrogen phosphate R in water R and dilute to1000.0mL with the same solvent.1M Phosphate buffer solution pH8.0.4007800.Dissolve136.1g of potassium dihydrogen phosphate R in water R,adjust the pH with1M sodium hydroxide.Dilute to 1000.0mL with water R.1M Tris-hydrochloride buffer solution pH8.0.4012700. Dissolve121.1g of tris(hydroxymethyl)aminomethane R and 1.47g of calcium chloride R in900mL of water R.Adjust the pH with hydrochloric acid R and dilute to1000.0mL with water R.Tris-hydrochloride buffer solution pH8.0.4012300. Dissolve1.21g of tris(hydroxymethyl)aminomethane R and 29.4mg of calcium chloride R in water R.Adjust the pH with 1M hydrochloric acid and dilute to100.0mL with water R. Tris-sodium acetate buffer solution pH8.0.4013100. Dissolve6.3g of tris(hydroxymethyl)aminomethane R and 4.9g of anhydrous sodium acetate R in900mL of water R. Adjust to pH8.0with sulfuric acid R and dilute to1000mL with water R.Tris-sodium acetate-sodium chloride buffer solutionpH8.0.4013200.Dissolve30.0g of tris(hydroxymethyl)aminomethane R,14.5g of anhydrous sodium acetate R and14.6g of sodium chloride R in900mL of water R.Add0.50g of bovine albumin R.Adjust to pH8.0with sulfuric acid R and dilute to1000mL with water R.Tris(hydroxymethyl)aminomethane buffer solution pH8.1. 4006200.Dissolve0.294g of calcium chloride R in40mL oftris(hydroxymethyl)aminomethane solution R and adjust the pH with1M hydrochloric acid.Dilute to100.0mL with water R.Tris-glycine buffer solution pH8.3.4006300.Dissolve6.0g of tris(hydroxymethyl)aminomethane R and 28.8g of glycine R in water R and dilute to1000.0mL with the same solvent.Dilute1volume to10volumes with water R immediately before use.Tris-hydrochloride buffer solution pH8.3.4011800. Dissolve9.0g of tris(hydroxymethyl)aminomethane R in2.9L of water R.Adjust the pH with1M hydrochloric acid.Adjust the volume to3L with water R.0.05M Tris-hydrochloride buffer solution pH9.0.4013500. Dissolve0.605g of tris(hydroxymethyl)aminomethane R in water R.Adjust the pH with1M hydrochloric acid and dilute to100.0mL with water R.Barbital buffer solution pH8.4.4006400.Dissolve8.25g of barbital sodium R in water R and dilute to 1000.0mL with the same solvent.Tris-EDTA BSA buffer solution pH8.4.4006500. Dissolve6.1g of tris(hydroxymethyl)aminomethane R,2.8g of sodium edetate R,10.2g of sodium chloride R and10gof bovine albumin R in water R,adjust to pH8.4using1M hydrochloric acid and dilute to1000.0mL with water R.Tris(hydroxymethyl)aminomethane-EDTA buffer solution pH8.4.4006600.Dissolve5.12g of sodium chloride R,3.03g oftris(hydroxymethyl)aminomethane R and1.40g of sodium edetate R in250mL of distilled water R.Adjust the pH to8.4 using hydrochloric acid R.Dilute to500.0mL with distilled water R.Guanidine-tris(hydroxymethyl)aminomethane-EDTA buffer solution pH8.5.4014600.Dissolve1.0g of sodium edetate R,12.1g oftris(hydroxymethyl)aminomethane R and57.0g of guanidine hydrochloride R in35mL of water R.Adjust topH8.5with hydrochloric acid R and dilute to100mL with water R.。
Diva Decloaker 10X Pretreatment Reagent 说明书
Intended Use:For In Vitro Diagnostic UseHeat induced antigen retrieval of formalin-fixed paraffin-embedded (FFPE) tissues for immunohistochemistry (IHC) procedures. The clinical interpretation of any staining or its absence should be complimented by morphological studies using proper controls and should be evaluated within the context of the patient's clinical history and other diagnostic tests by a qualified pathologist.Summary & Explanation:Diva Decloaker is a heat retrieval solution that is compatible with virtually all antibodies and eliminates the need for multiple buffers including citrate buffer, EDTA or high pH tris buffers. Antibody titers are doubled and tripled when compared to citrate buffer, pH 6.0. Diva Decloaker incorporates Assure™ tech nology, a color-coded high temperatures pH indicator solution. The end-user is assured by visual inspection that the solution is at the correct dilution and pH. This product is specially formulated for superior pH stability at high temperatures and will help prevent the possibility of losing pH sensitive antigens. Diva Decloaker is non-toxic, non-flammable, odorless and sodium azide and thimerosal free.Known Applications:Immunohistochemistry (formalin-fixed paraffin-embedded tissues) Supplied As:100mlDiva Decloaker, 10X concentrate (DV2004LX)500mlDiva Decloaker, 10X concentrate (DV2004MX)Materials and Reagents (Needed But Not Provided): Microscope slides, positively chargedDesert Chamber* (Drying oven)Positive and negative tissue controlsXylene (Could be substituted with xylene substitute*)Ethanol or reagent alcoholDecloaking Chamber* (Pressure cooker)Deionized or distilled waterWash buffer*(TBS/PBS)Enzyme digestion*Avidin-Biotin Blocking Kit*(Labeled Streptavidin Kits Only) Peroxidase block*Protein block*Primary antibody*Negative control reagents*Detection kits*Detection components*Chromogens*Hematoxylin*Bluing reagent*Mounting medium** Biocare Medical Products: Refer to a Biocare Medical catalog for further information regarding catalog number and ordering information. Certain reagents listed above are based on specific application and detection system used. Storage and Stability:Store at room temperature. Do not use after expiration date printed on vial. If reagents are stored under conditions other than those specified in the package insert, they must be verified by the user. Diluted reagents should be used promptly; any remaining reagent should be stored at room temperature.Protocol Recommendations:1. Deparaffinize tissues and hydrate to water. If necessary, block for endogenous peroxidase and wash in DI water.2. Dilute concentrated Diva Decloaker at a ratio of 1:10 (1 ml Diva to 9 ml of deionized water).3. Place slides into 1X retrieval solution in a slide container (e.g. Coplin Jar, Tissue -Tek™ staining dish or metal slide canister).4. Retrieve sections under pressure using Biocare's Decloaking Chamber. Follow the recommendations on the antibody data sheet and Decloaking Chamber User Manual.5. Check solution for appropriate color change. (See Technical Note #1)6. Gently rinse by gradually adding DI water to the solution, then remove slides and rinse with DI water.Technical Notes:1. Concentrated Diva Decloaker is a bright yellow color. RTU or 1X solution is a pale yellow color. When the solution reaches 80-125°C, the solution turns yellow and indicates that the high temperature solution is at correct pH. Should the pH rise above 7.0, the solution turns a fuschia red color. Should the pH drop too low, thesolution turns a pink color.2. If using Biocare’s Desert Chamber Pro (a programmable turbo-action drying oven), dry sections at 25ºC overnight or at 37ºC for 30-60 minutes and then dry slides at 60ºC for 30 minutes.3. Use positive char ged slides (use Biocare’s Kling-On HIER Slides) and cut tissues at 4-5 microns. Do not use any adhesives in the water bath. Poor fixation and processing of tissues will cause tissue sections to fall off the slides, especially fatty tissues such as breast. Tissues should be fixed a minimum of 6-12 hours.4. Protocol time and temperatures for HIER can vary depending on the Decloaking Chamber model used. Please refer to the relevant Decloaking Chamber manual for appropriate protocol times and temperatures.Limitations:The protocols for a specific application can vary. These include, but are not limited to: fixation, heat-retrieval method, incubation times, tissue section thickness and detection kit used. Due to the superior sensitivity of these unique reagents, the recommended incubation times and titers listed are not applicable to other detection systems, asresults may vary. The data sheet recommendations and protocols are based on exclusive use of Biocare products. Ultimately, it is the responsibility of the investigator to determine optimal conditions. The clinical interpretation of any positive or negative staining should be evaluated within the context of clinical presentation, morphology and other histopathological criteria by a qualified pathologist. The clinical interpretation of any positive or negative staining should be complemented by morphological studies using proper positive and negative internal and external controls as well as other diagnostic tests.Catalog Number: DV2004 LX, MX Description: 100, 500 ml, concentrateQuality Control:Refer to CLSI Quality Standards for Design and Implementation of Immunohistochemistry Assays; Approved Guideline-Second edition (I/LA28-A2). CLSI Wayne, PA, USA (). 2011 Precautions:1. This product is not classified as hazardous. The preservative used in this reagent is Proclin 300 and the concentration is less than 0.25%. Overexposure to Proclin 300 can cause skin and eye irritation and irritation to mucous membranes and upper respiratory tract. The concentration of Proclin 300 in this product does not meet the OSHA criteria for a hazardous substance. Wear disposable gloves when handling reagents.2. Specimens, before and after fixation, and all materials exposed to them should be handled as if capable of transmitting infection and disposed of with proper precautions. Never pipette reagents by mouth and avoid contacting the skin and mucous membranes with reagents and specimens. If reagents or specimens come in contact with sensitive areas, wash with copious amounts of water.3. Microbial contamination of reagents may result in an increase in nonspecific staining.4. Incubation times or temperatures other than those specified may give erroneous results. The user must validate any such change.5. Do not use reagent after the expiration date printed on the vial.6. The SDS is available upon request and is located at /.7. Consult OSHA, federal, state or local regulations for disposal of any toxic substances. Proclin is a trademark of Rohm and Haas Company, or of its subsidiaries or affiliates.Troubleshooting:Follow the antibody specific protocol recommendations according to data sheet provided. If atypical results occur, contact Biocare's Technical Support at 1-800-542-2002.。
维萨拉工业测量产品手册说明书
维萨拉工业测量产品手册湿度 | 温度 | 露点 | 二氧化碳 | 沼气 | 油中水分 | 连续监测系统 |溶解气体分析系统 | 过氧化氢 | 压力 | 气象 | 服务支持观测让世界更美好维萨拉的工业测量业务领域产品能够帮助客户了解工艺过程。
我们的产品为客户提供准确可靠的测量数据,帮助客户做出优化工业过程的决策,从而提高过程效率、产品质量、生产力和产量,同时减少能源消耗、浪费和排放。
我们的监测系统还能帮助客户在受监管的环境中运营,以履行监管合规性。
维萨拉工业测量服务于多种类型的运营环境,从半导体工厂和高层建筑,到发电厂和生命科学实验室,对环境条件的可靠监测是实现成功运营的先决条件。
维萨拉的测量产品和系统广泛应用于监测温度、湿度、露点、气压、二氧化碳、汽化过氧化氢、甲烷、油中水、变压器油中溶解气体和液体浓度等参数。
我们的生命周期服务可在测量仪表的整个使用寿命内提供维护。
作为值得信赖的合作伙伴,我们通过在产品和系统生命周期中保证准确的测量数据来支持客户做出可持续的决策。
本产品目录对我们的产品进行整体的介绍,以帮助您选择适合您需求的产品。
如需更多信息,请通过以下方式联系我们:销售热线:400 810 0126电子邮箱:**********************公司网址:扫描二维码,关注维萨拉企业微信3目 录Indigo系列变送器Indigo200系列数据处理单元 (7)Indigo300数据处理单元 (9)Indigo510数据处理单元 (12)Indigo520数据处理单元 (15)用于抽检和校准的手持设备Indigo80手持式显示表头 (18)HMP80系列手持式湿度和温度探头 (21)DMP80系列手持式露点和温度探头 (23)HM70手持式湿度和温度仪 (26)HUMICAP® 手持式湿度温度仪表HM40系列 (29)DM70手持式露点仪 (33)MM70适用于现场检测的手持式油中微量水分和温度测试仪 (36)湿度和温度用于测量相对湿度的维萨拉HUMICAP® 传感器 (38)如何为高湿度应用选择合适的湿度仪表 (40)Insight PC机软件 (44)HMP1墙面式温湿度探头 (46)HMP3一般用途湿度和温度探头 (48)HMP4相对湿度和温度探头 (51)HMP5相对湿度和温度探头 (54)HMP7相对湿度和温度探头 (57)HMP8相对湿度和温度探头 (60)HMP9紧凑型湿度和温度探头 (63)TMP1温度探头 (66)适用于苛刻环境中湿度测量的HMT330系列温湿度变送器 (68)HMT370EX系列本安型温湿度变送器 (78)HMT310温湿度变送器 (84)HUMICAP® 温湿度变送器HMT120和HMT130 (87)适用于高性能暖通空调应用的HMW90系列湿度与温度变送器 (90)HMD60系列湿度和温度变送器 (92)HMD110/112和HMW110/112湿度和温度变送器 (96)适用于楼宇自动化高精度室外测量的HMS110系列温湿度变送器 (99)HMDW80系列温湿度变送器 (101)适用于楼宇自动化应用室外测量的HMS80系列温湿度变送器 (105)HMM100湿度模块 (107)适用于OEM应用的HMM105数字湿度模块 (109)HMM170温湿度模块 (111)INTERCAP® 温湿度探头HMP60 (113)4INTERCAP® 温湿度探头HMP63 (115)HUMICAP® 温湿度探头HMP110 (117)HUMICAP® 温湿度探头HMP113 (120)SHM40结构湿度测量套件 (122)HMK15湿度校准仪 (125)DTR500太阳辐射和雨水防护罩 (127)HMT330MIK气象安装套件 (129)适用于动力汽轮机进气测量的HMT300TMK汽轮机安装组件 (131)露点Vaisala DRYCAP® 传感器用于测量干燥过程中的湿度 (133)DMP5露点和温度探头 (135)DMP6露点探头 (138)DMP7露点和温度探头 (140)DMP8露点和温度探头 (142)DMT340系列露点和温度变送器 (145)适用于高温应用的DMT345和DMT346露点变送器 (151)DMT152露点变送器 (155)DMT143露点变送器 (157)DMT143L露点变送器 (160)用于冷冻干燥机的DMT132露点变送器 (162)DM70用DSS70A便携式采样系统和采样室 (164)DPT146露点和气压变送器 (166)DPT145多参数变送器 (168)二氧化碳适用于苛刻环境的维萨拉CARBOCAP® 测量传感器 (171)GMP343二氧化碳探头 (173)适用于CO2恒温箱的GMP231二氧化碳探头 (176)GMP251二氧化碳探头 (178)GMP252二氧化碳探头 (181)GM70手持式二氧化碳测试仪 (184)适用于苛刻通风要求应用的GMW90系列二氧化碳及温湿度变送器 (187)适用于智能控制通风系统 (DCV) 的GMW80系列二氧化碳、湿度和温度一体变送器 (190)按需控制通风系统中的GMD20系列二氧化碳变送器 (193)GMD110管道安装式二氧化碳变送器 (195)沼气MGP261多气体探头 (197)MGP262多气体探头 (199)油中水用于测量油中微水的维萨拉HUMICAP® 传感器 (201)MMP8油中水分探头 (203)MMT330系列油中微量水分与温度变送器 (205)5MMT310系列油中微量水分与温度变送器 (209)MMT162油中微量水分和温度变送器 (211)连续监测系统维萨拉viewLinc企业版服务器版本5.1 (213)AP10 VaiNet无线接入点 (215)用于连续监测系统的RFL100无线数据记录仪 (218)HMP115温湿度探头 (223)TMP115宽范围温度探头 (225)维萨拉温度与相对湿度数据记录仪系列DL2000 (227)维萨拉通用输入数据记录仪系列DL4000 (229)维萨拉多应用温度数据记录仪DL1016/1416 (231)维萨拉热电偶数据记录仪系列DL1700 (233)维萨拉中端温度、湿度及触点通道数据记录仪 (235)维萨拉vNet以太网供电数据记录仪接口 (238)溶解气体分析OPT100 Optimus™ 溶解气体分析(DGA)监测系统 (240)MHT410变压器油中微量水分、氢气和温度分析仪 (244)过氧化氢用于测量汽化过氧化氢、相对饱和度和相对湿度的维萨拉PEROXCAP® 传感器 (246)用于过氧化氢、湿度和温度测量的HPP270系列探头 (249)压力用于测量压力的维萨拉BAROCAP® 传感器 (253)PTU300气压、湿度和温度一体变送器 (255)适用于专业气象、航空与工业用户的PTB330数字式气压计 (260)气压传递标准PTB330TS (262)PTB210数字气压计 (265)PTB110气压计 (267)将风引起误差降低的SPH10/20静压头 (269)气象Vaisala用于工业应用测量的风和气象传感器技术 (271)风测量装置WA15 (273)WINDCAP® 超声波风传感器WMT700系列 (276)气象变送器WXT530系列 (278)服务支持面向仪表全生命周期服务 (280)67功能•数据处理单元 USB-C 端口支持使用通用 USB 电缆连接到维萨拉Insight PC 软件•数字和图形彩色显示屏(针对模拟型号提供可选的不带显示屏的款式)•IP65 外壳•24 V AC/DC 电源输入•Indigo201:3 个模拟输出(mA 或 V)•Indigo202:RS-485,带有Modbus ® RTU•2 个可配置的继电器维萨拉 Indigo200 系列数据处理单元是一种主机设备,它显示来自维萨拉 Indigo 兼容探头的测量值,同时也可通过模拟信号、Modbus RTU 通信或继电器将这些测量值传输到自动化系统。
大豆蚜有翅成蚜触角感器超微结构观察
h t p ://hljnykx haasep cnDQI :10 11942/j issni002-2767 2021 06. 0047:黑龙江农业科学2021(6):47-51Heilongjiang Agricultural Sciences王玲,来永才,毕影东,等•大豆蚜有翅成蚜触角感器超微结构观察[J ]•黑龙江农业科学,2021(6)47-51,52.大豆蚜有翅成蚜触角感器超微结构观察王 玲1,来永才1,毕影东1,李 炜1,刘 淼1,樊 超1,杨 帅2(1.黑龙江省农业科学院 耕作栽培研究所,黑龙江 哈尔滨150086;2.黑龙江省农业科学院马铃薯研究所,黑龙江哈尔滨150086)摘要:为明确大豆蚜{Aphis glycines Matsumura)触角及其感器的外部特征,利用扫描电镜技术,对大豆蚜有 翅成蚜触角的整体形态及触角感器的类型、形态、数量与分布进行超微结构观察。
结果表明:大豆蚜有翅成蚜触角呈丝状,由柄节、梗节和鞭节组成,其中鞭节由4个亚节组成。
触角上分布着6种不同类型的嗅觉感器,分别是板型感器(placoid sensillum, ps)、腔锥形感器(coeloconic peg,cp )、毛形感器[型(trichoid sensillum type I ,tsl )、毛形感器 II 型(trichoid sensillum type H ,tsH )、钟形感器(campaniform sensillum , cs)及周边具 橛感器(peripheral scolopidia ,psc ) …并进一步对大豆蚜有翅成蚜触角各类型感器的功能进行了分析与预测。
关键词:大豆蚜;触角感器;扫描电镜大豆蚜(Aphis glycines Matsumura)属半翅 目(Hemiptera)、蚜科(Aphididae)、蚜属(Aphis ),是栽培大豆(.Glycine max Linn .)的主要害虫之 一[1]。
德国LUMi全功能稳定性分析仪
The NEXT STEP® in Dispersion Analysis
Newcomer Course 2009, 13/47
亚铭(北京)科技有限公司
粒度分布(PSD)
粒度分布(PSD) - 计算方式
• 速率分布 • 强度–重量粒度分布 • 体积–重量粒度分布
• 2种模态硅石悬浮液空间与时间分离透射(消光)轮廓图
Newcomer Course 2009, 11/47
亚铭(北京)科技有限公司
其它应用
加工过程最优化对乳化液均化的影响 表面活性剂的剂量对碳黑悬浮的稳定性影响
药物乳剂的乳化物
未加工牛奶 vs. 加工牛奶
The NEXT STEP® in Dispersion Analysis
Newcomer Course 2009, 12/47
亚铭(北京)科技有限公司
The NEXT STEP® in Dispersion Analysis
Newcomer Course 2009, 17/47
产品应用领域
• 纳米颗粒表面改质或活 性剂 • 燃料电池 • 墨水,墨粉,涂料,染料,颜 料和分散剂 • 食品和饮料 • 药物和化妆品 • 感光乳剂 • 精细化工产品 / 陶瓷和 水泥 • 化学 / 聚合悬浮液 • 高分子,乳液,胶粘剂和凝 胶体 • 脂质体,细胞和生化胶体 • 润滑剂,原油和沥青 • 纸浆和造纸工业 • 污泥,泥浆和废水处理 • 化学机械抛CMP's抛光 剂和研磨磨料 • 石油与石化工业 • 农业化肥化学用品
可选择性的倾斜角度 : 0 ˚, 5 ˚, 10 ˚, 15 ˚, 20˚
The NEXT STEP® in Dispersion Analysis
谷胱甘肽还原酶测定试剂盒 (谷胱甘肽底物法)产品技术要求北京世纪沃德生物
谷胱甘肽还原酶测定试剂盒(谷胱甘肽底物法)适用范围:用于体外定量测定人血清、血浆中谷胱甘肽还原酶(GR)的含量。
1.1 包装规格校准品(选配):1.0mL×1;1.0mL×2;1.0mL×5质控品(选配):水平1: 1.0mL×1;1.0mL×2;1.0mL×5水平2: 1.0mL×1;1.0mL×2;1.0mL×5 1.2主要组成成分校准品靶值批特异,详见校准品瓶签;质控品质控范围批特异,详见质控品瓶签。
2.1 外观试剂1为无色澄清液体;试剂2为无色澄清液体;校准品、质控品为白色至黄色冻干粉,复溶后为无色至黄色液体;试剂盒标签标识清晰,外包装完整无损。
2.2 装量试剂液体成分的装量不少于瓶签标示量。
2.3 试剂空白2.3.1试剂空白吸光度在340nm处测定试剂空白吸光度,应≤1.5。
2.3.2试剂空白吸光度变化率在340nm处测定试剂空白吸光度变化率(ΔA/min)应≤0.01。
2.4 分析灵敏度测试70U/L的被测物时,吸光度变化率(ΔA/min)的绝对值应≤0.5。
2.5准确度待检系统与已上市比对系统测值的相关系数r≥0.975;在[10,30]U/L区间内,绝对偏差应不超过±4.5U/L;在(30,184]U/L区间内,相对偏差应不超过±15%。
2.6 线性2.6.1在[10,184]U/L区间内,线性相关系数r≥0.990;2.6.2在[10,30]U/L区间内,线性绝对偏差应不超过±4.5U/L;在(30,184]U/L 区间内,线性相对偏差应不超过±15%。
2.7 精密度2.7.1重复性测试高、低两浓度样本,其结果的变异系数CV应≤10%。
2.7.2 批间差随机抽取三批试剂盒,测试同一份样本,批间相对极差(R)应≤10%。
2.7.3瓶间均匀性校准品、质控品瓶间变异系数CV≤10%。
泊洛沙姆的型号
407-0 泊洛沙姆 Poloxamer[别名] 普流罗尼克:Poloxalkol: Monolan;Supronic'PolyvethylenePropylene Glycol;Pluronic.[来源与制法] 本品为合成品,其合成方法是先将氧化丙烯缩合到丙二醇基上,再将氧化乙烯缩合到聚(氧丙烯)基的两端而制得的氧乙烯、氧丙烯嵌段聚合物,共聚物分子中聚乙烯亲水链占10~80%,余下的则为聚氧丙烯亲脂链,不同的规格型号,所占比例各不相同。
[性状] 本品规格型号有多种,随聚合度增大,物态从液体、半固本至蜡状固体,从难溶于水的液体到易溶于水的固体。
均有较高的HLB值。
有些型号的产品如泊洛沙姆 124、188等,在通常使用的浓度,实际上是无色、无臭、无味的。
溶液可以高压蒸气灭菌不会分解破坏。
分子中存在众多醚键,能与水的质子形成氢键,温度升高到一定程度对氢键破坏而出现起昙现象,10%水溶液的昙点在80~90℃之间。
有些型号的产品如泊洛沙姆108、188、124,l%浓度昙点在l00℃以上。
多数型号的产品在水中易溶,溶解度随分子中氧乙烯含量的增加而增加,在矿物油中不溶,在乙醚和石油醚中几乎不溶,溶于无水乙醇、乙酸乙酯、氯仿。
2.5%水溶液的,H在5.0~7.5之间,注射用者pH在6.0~ 7.0。
本品有一定的起泡性,1%水溶液,在 40℃时,400ml/min的流速,泡沫高度为 600mm。
水溶液在空气中较稳定,遇光则使 pH值下降。
本品属于非离子表面活性剂,具有良好的乳化性,同系物中,聚氧丙烯含量较高,乳化性越好。
对矿物油和烷烃类的乳化性比对脂肪油的乳化性好。
临界胶团浓度(CMC值)约为0.2%,胶团结构的分子数在8个以下。
分子量大的同系物具有在水溶液中形成凝胶(Gels)的性质。
本品对酸、碱水溶液和金属离子稳定。
泊洛沙姆部分型号产品的理化参数泊洛沙姆型号物理形态氧乙烯含量(%) 不饱和值mmol 熔点℃粘度(>7℃)cp HLB 最低凝胶浓度浓%W/W124 液体46.7±1.9 0.020±0.008 16 440 16188 固体81.1±0.63 0.26±0.004 52 100 29 60237 固体72.4±1.9 0.034±0.008 49 700 24 65338 固体83.1±1.7 0.031±0.008 57 2800 27 30407 固体73.2±1.7 2.048±0.017 56 3100 22 20[作用与用途] Poloxamers(Px)为一大类非离子表面活性剂,具有上述各种优良性质,现已广泛用于制药工业,是一类优良的药物制剂新辅料,其作用与用途如下;1.作乳化剂和稳定剂用于制备乳剂, Pxl88是制备静脉脂肪乳剂良好的乳化剂,形成O/W型乳剂,用量0.1~5%。
琼脂糖凝胶4FF
琼脂糖凝胶4FF琼脂糖凝胶4FF是在琼脂糖凝胶4B的基础上经过两次交联形成的高交联基质,微球的化学稳定性及物理性能显著增强,刚性增加,流速更快,使产品处理时间大大缩短。
可用于生物大分子的凝胶层析。
1.外观本品为白色球状凝胶,无嗅、无味、无肉眼可见杂质。
2.理化指标项目指标基质4%交联琼脂糖排阻极限6×104~2×107(球蛋白)形状球形粒径45~165μm最高流速300cm/h*耐压0.30MPapH适用范围2~14(短时间,在位清洗),2~12(长时间)化学稳定性以下溶液中40℃下稳定:2mol/L NaOH;70%EtOH;30%异丙醇;30%乙腈;1%SDS;6mol/L盐酸胍;8mol/L尿素*检测条件:层析柱10mm×300mm*柱床高15cm,25℃,流动相为0.1mol/LNaCl3包装产品以聚胺酯瓶密封包装,外贴标签,注明“品名、体积、颗粒大小”等内容。
4贮存产品应密封贮存在4℃~25℃(保存溶液为20%乙醇),通风、干燥、清洁的地方。
不能冷冻。
用过的柱子贮存在4℃(20%乙醇)。
5注意事项本品应避免与氧化剂接触,避免长时间暴露在空气中。
6.运输运输中应避免日晒、雨淋、重压,严禁与有毒、有害物品混运。
7保质期5年。
8应用本产品具有很高的化学稳定性、高流速、较好的机械性能、可多次重复使用等特点,非特异性吸附低,回收率高,可用有机溶剂及1~2mol/L的NaOH在位清洗,适用于工业规模生产,广泛用于生物制药和生物工程下游蛋白质、核酸及多肽的凝胶色谱纯化。
8.1装柱凝胶过滤介质的使用对装柱的要求较高,为了保证分离效果,一般通过柱子上加一个装柱器来使分离柱装满凝胶,或采用带有轴向加压装置的柱子。
凝胶柱床一般高于60cm。
装柱效果可用染料或丙酮-水溶液进行检验。
以下过程为通用介质装填过程。
若为带有轴向加压装置的柱子,可在柱床稳定后将柱床压紧,接好管路。
(1)让所有的材料和试剂达到室温。
Rink Amide Resin_0_13653-84-4_Apexbio
For obtaining a higher solubility , please warm the tube at 37°C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
产品说明书
化学性质
产品名: Cas No.: 分子量: 分子式:
Rink Amide Resin 13653-84-4 318.32 C20H14O4
【脉铂医药】MedBio143360-00-3SMIP004技术资料
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11190
2-[(2,6-dioxocyclohexyl)methyl]cyclohexane-1,3-dione
Apoptosis Inhibitor
54135-60-3
25mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11328
CAS
包装
纯度
MedBio
MED11270
VU0661013
VU661013
2131184-57-9
10mg
≥98%
品牌
货号
中文名称
英文名称
CAS
包装
纯度
MedBio
MED11183
(3S)-3-[[叔丁氧羰基]氨基]-5-氟-4-氧代-戊酸甲酯
Boc-D-FMK
187389-53-3
10mg
≥98%
【脉铂医药】MedBio143360-00-3SMIP004技术资料
1、SMIP004物理参数:
常用名
SMIP004
英文名
SMIP004
CAS号
143360-00-3
分子量
205.29600
密度
1.003g/cm3
沸点
343ºC at 760mmHg
分子式
C13H19NO
熔点
无资料
闪点
206.1ºC
2、SMIP004物理化学性质:
密度
1.003g/cm3
沸点
343ºC at 760mmHg
生物指示剂
生物指示剂LT另外根据客户要求可提供:生孢梭菌(Clostridium sporogenes),枯草芽孢杆菌(B. subtilis),巨大芽孢杆菌(B. megaterium),蜡状芽孢杆菌(B. cereus)等的芽孢悬液。
2.工业生物指示剂工业生物指示剂是根据工业企业实际情况,按照标准要求定制加工而成,以满足企业的特殊需求,通常采用不同的载体材料和包装形式,例如钢片、钢线、纸片、棉线、塑料片和滑石粉等,它与芽孢条、自含式等标准生物指示剂相比更具优势。
CICC可按照客户要求提供定制工业生物指示剂。
染菌滑石粉CICC研制的标准专用染菌滑石粉,以符合标准要求的滑石粉为载体,选用CICC 自行生产的微生物材料萎缩芽孢杆菌ATCC 9372芽孢悬液,按标准要求精制而成,每批染菌滑石粉产品均经过芽孢含量检验,确保质量稳定。
该产品适用于评定屏障材料对携菌微粒阻穿透性的实验方法,适用于国家医药行业手术衣标准《病人、医护人员和器械用手术单、手术衣和洁净服》(YY/T 0506-2009)、国际标准ISO 22612:2005 Clothing for protection against infectious agents -- Test method for resistance to dry microbial penetration(传染介质防护服--防干微生物渗入的试验方法)。
产品参数:产品名称染菌滑石粉微生物材料萎缩芽孢杆菌(B. atrophaeus)ATCC 9372芽孢含量108 CFU/g规格0.5g+0.1 g /瓶粒度<800目(95%<15μm)贮藏条件2~8℃,避免阳光直射和接触灭菌剂。
有效期生产日起12个月染菌石英粉CICC研制的标准专用染菌石英粉,以符合标准要求的石英粉为载体,选用CICC 自行生产的微生物材料萎缩芽孢杆菌ATCC 9372芽孢悬液,按标准要求精制而成,每批染菌石英粉产品均经过芽孢含量检验,产品质量稳定。
FDA兽药管理目录4
Section 2.0 - Active IngredientsApplicationActive Ingredients Trade NameNumber005-2362-Mercaptobenzothiazole Sulfodene® Medication for Dogs015-030Acepromazine Maleate PromAce® Injectable032-702Acepromazine Maleate PromAce® Tablets117-531Acepromazine Maleate Acepromazine Maleate Injection117-532Acepromazine Maleate Acepromazine Maleate Tablets200-319Acepromazine Maleate Acepromazine Maleate Injection200-361Acepromazine Maleate Acepromazine Maleate Injection011-582Acetazolamide Sodium Vetamox Soluble Powder011-700Acetylsalicylic Acid, Methylprednisolone Cortaba® Tablets141-406Afoxolaner NexGard™014-250Aklomide, Sulfanitran Novastat Type A Medicated Premix034-536Aklomide, Roxarsone Aklomix Type A Medicated Article, Aklomix-3034-537Aklomide, Roxarsone, Sulfanitran Novastat-3 Type A Medicated Article035-388Aklomide, Sulfanitran Novastat-W110-048Albendazole Valbazen®128-070Albendazole Valbazen®140-934Albendazole Valbazen®141-180Albuterol Sulfate Torpex™141-342Alfaxalone Alfaxan®131-310Altrenogest Regu-Mate®141-222Altrenogest Matrix®127-892Amikacin Sulfate Amiglyde-V200-178Amikacin Sulfate Amikacin Sulfate Injection200-181Amikacin Sulfate AmiMax™ E Solution043-078Aminopentamide Hydrogen Sulfate Centrine Oral Tablets043-079Aminopentamide Hydrogen Sulfate Centrine Injectable092-116Aminopentamide Hydrogen Sulfate, Ketamine Ketaset® PlusHydrochloride, Promazine Hydrochloride011-877Aminopropazine Fumarate Jenotone Tablets013-181Aminopropazine Fumarate, Neomycin Sulfate Jenomycin Tablets034-477Aminopropazine Fumarate Jenotone Solution120-299Amitraz Mitaban® Liquid Concentrate009-339Ammonium Chloride, Caramiphen Edisylate Carafen Cough Syrup, Carafen Cough Tablets055-078Amoxicillin Trihydrate Amoxi-Tabs055-080Amoxicillin Trihydrate Amoxi-DoserFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 1 of 70Number055-081Amoxicillin Trihydrate Amoxi-Tabs055-085Amoxicillin Trihydrate Amoxi-Drop® Oral Suspension055-087Amoxicillin Trihydrate Amoxi-Bol055-088Amoxicillin Trihydrate Amoxi-Sol055-089Amoxicillin Trihydrate Amoxi-Inject (Cattle)055-091Amoxicillin Trihydrate Amoxi-Inject (Dogs and Cats)055-099Amoxicillin Trihydrate, Clavulanate Potassium Clavamox® Tablets055-100Amoxicillin Trihydrate Amoxi-Mast055-101Amoxicillin Trihydrate, Clavulanate Potassium Clavamox® Drops065-492Amoxicillin Trihydrate Biomox065-495Amoxicillin Trihydrate Biomox®141-004Amoxicillin Trihydrate Robamox®-V141-005Amoxicillin Trihydrate Robamox®-V TabletsKanfosone Ointment043-784Amphomycin Calcium, Hydrocortisone Acetate,Kanamycin Sulfate047-997Amphomycin Calcium, Hydrocortisone Acetate,Amphoderm OintmentKanamycin Sulfate055-013Ampicillin Anhydrous Omnipen 250 mg055-084Ampicillin Sodium Amp-Equine200-335Ampicillin sodium Ampicillin Sodium055-030Ampicillin Trihydrate Polyflex®055-036Ampicillin Trihydrate Princillin Capsules 125 mg, Princillin Capsules 250 mg,Princillin Capsules 500 mg055-042Ampicillin Trihydrate Ampi-Tab055-050Ampicillin Trihydrate Princillin Soluble Powder055-056Ampicillin Trihydrate Princillin Bolus055-061Ampicillin Trihydrate Princillin "125" For Oral Suspension055-064Ampicillin Trihydrate Princillin Injection055-066Ampicillin Trihydrate Princillin Injection055-071Ampicillin Trihydrate Princillin Injection 200 mg055-074Ampicillin Trihydrate Ampi-Bol055-079Ampicillin Trihydrate Ampi-Ject200-180Ampicillin Trihydrate Ampicillin Trihydrate012-350Amprolium Amprovine 25%, CORID® 25% Type A Medicated Article 013-149Amprolium Amprovine 9.6% Solution013-461Amprolium, Ethopabate, Roxarsone Broiler PMX No.1620, Amprol Plus®, Amprol Hi-E®, AmprolPlus + Nitro®013-663Amprolium Purina® Liquid Amprol033-165Amprolium Amprovine 20% Soluble Powder, Corid 20% Soluble Powder FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 2 of 70NumberAmprol HI-E® Plus036-304Amprolium, Bacitracin Methylene Disalicylate,EthopabateAmp Ethopabate CTC® Sodium Sulfate 036-361Amprolium, Chlortetracycline Calcium Complex,Ethopabate, Sodium SulfateErythro® (Low Lev) / Amp plus Etho 038-242Amprolium, Arsanilic Acid, ErythromycinThiocyanate, Ethopabate041-178Amprolium, Ethopabate, LincomycinAmprol® Plus / Lincomix® / RoxarsoneHydrochloride Monohydrate, RoxarsoneLincomix® / Amprol Plus044-820Amprolium, Ethopabate, LincomycinHydrochloride Monohydrate049-179Amprolium, Ethopabate, Roxarsone Amprol HI-E® / RoxarsoneAmprol HI-E® / BMD® / Roxarsone 049-180Amprolium, Bacitracin Methylene Disalicylate,Ethopabate, Roxarsone095-543Amprolium, Bambermycins, Ethopabate Amprol HI-E® & Bambermycins, Amprol HI-E® / Flavomycin®3-Nitro® / Amprol HI-E® / Flavomycin®095-547Amprolium, Bambermycins, Ethopabate,Roxarsone095-548Amprolium, Bambermycins, Roxarsone3-Nitro® / Amprol / Flavomycin®095-549Amprolium, Bambermycins, Ethopabate,3-Nitro® / Amprol / Flavomycin®RoxarsoneAmprol HI-E® / Baciferm® / 3-Nitro®105-758Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone114-794Amprolium, Bacitracin Zinc, Ethopabate Baciferm® / Amprol HI-E® Premix118-507Amprolium, Carbarsone Amprol® / Carb-O-Sep®122-822Amprolium, Ethopabate, Virginiamycin Amprol HI-E® / Stafac®130-185Amprolium, Bambermycins Flavomycin® / Amprolium3-Nitro® / Amprol® / BMD®141-142Amprolium, Bacitracin Methylene Disalicylate,Roxarsone141-156Amprolium, Bacitracin Methylene Disalicylate Amprol® / BMD®200-205Amprolium, Bacitracin Zinc, Ethopabate Albac® / Amprol Hi-E®3-Nitro® / Albac® / Amprol Hi-E®200-214Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone3-Nitro® / Albac® / Amprol Hi-E®200-217Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone200-389Amprolium Amprolium 9.6% Oral Solution200-463Amprolium Amprolium 9.6% Oral Solution200-464Amprolium Ampromed™ for Calves200-482Amprolium AmproMed™ for Calves200-488Amprolium Ampromed™ P for Poultry200-496Amprolium AmproMed™ P for Poultry200-514Amprolium Boviprol™ 9.6% Oral Solution106-964Apramycin Sulfate Apralan® Soluble Powder126-050Apramycin Sulfate Apralan® 75 Soluble PowderErythro® (High Lev) / Zoalene plus Arsanilic Acid 038-241Arsanilic Acid, Erythromycin Thiocyanate,ZoaleneFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 3 of 70Number038-242Amprolium, Arsanilic Acid, ErythromycinErythro® (Low Lev) / Amp plus EthoThiocyanate, Ethopabate038-624Arsanilic Acid, Erythromycin Thiocyanate Pro-Gallimycin-10006-623Arsenamide Sodium Caparsolate Sodium141-033Atipamezole Hydrochloride Antisedan®013-248Atropine, Trichlorfon Freed No. 10, Freed No. 25035-650Atropine, Trichlorfon Dyrex Powder042-548Attapulgite, Bismuth Subcarbonate, KanamycinAmforol® SuspensionSulfateAmforol® Veterinary Oral Tablets042-841Attapulgite, Bismuth Subcarbonate, KanamycinSulfate115-732Azaperone Stresnil InjectionAmprol HI-E® Plus036-304Amprolium, Bacitracin Methylene Disalicylate,Ethopabate039-646Bacitracin Methylene Disalicylate, Carbarsone Carb-O-GainBMD® 15 / Coyden 25®041-541Bacitracin Methylene Disalicylate, Clopidol,Roxarsone046-592Bacitracin Methylene Disalicylate BMD® 50 Granular A Type A Medicated Article, BMD® 30Type A Medicated ArticleAmprol HI-E® / BMD® / Roxarsone 049-180Amprolium, Bacitracin Methylene Disalicylate,Ethopabate, Roxarsone049-463Bacitracin Methylene Disalicylate, Monensin USP Coban® plus BMD®Coban® plus 3-NITRO® plus BMD®049-464Bacitracin Methylene Disalicylate, MonensinUSP, RoxarsoneEntromycin Powder065-107Bacitracin Methylene Disalicylate, StreptomycinSulfate065-280Bacitracin Methylene Disalicylate Soluble Fortracin Concentrate065-470Bacitracin Methylene Disalicylate BMD® Soluble, BMD® Soluble 50%, Solu-tracin 200, Solu-tracin 50Bac MD / Robenz®097-085Bacitracin Methylene Disalicylate, RobenidineHydrochloride098-378Bacitracin Methylene Disalicylate, Nicarbazin Nicarb® 25% and bacitracin methylene disalicylate099-150Bacitracin Methylene Disalicylate, Clopidol BMD® / Coyden 25®107-996Bacitracin Methylene Disalicylate, Lasalocid Avatec® / Fortracin Premix3-Nitro® / Avatec® / BMD®116-082Bacitracin Methylene Disalicylate, Lasalocid,Roxarsone116-088Bacitracin Methylene Disalicylate, Monensin3-Nitro® / BMD® / Coban®, 3-Nitro® / Coban® / Fortracin Sodium, Roxarsone3-Nitro® / Avatec® / Fortracin Broiler Premix 131-894Bacitracin Methylene Disalicylate, Lasalocid,Roxarsone3-Nitro® / Bio-Cox® / BMD®135-321Bacitracin Methylene Disalicylate, Roxarsone,Salinomycin Sodium135-746Bacitracin Methylene Disalicylate, SalinomycinBio-Cox® / BMD®SodiumFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 4 of 70Number138-456Bacitracin Methylene Disalicylate, MonensinSodiumCoban® / BMD®140-533Bacitracin Methylene Disalicylate, HalofuginoneHydrobromide, Roxarsone3-Nitro® / BMD® / Stenorol®140-584Bacitracin Methylene Disalicylate, HalofuginoneHydrobromideBMD / Stenorol®140-852Bacitracin Methylene Disalicylate, Narasin,Roxarsone3-Nitro® / BMD® / Monteban®140-853Bacitracin Methylene Disalicylate, Narasin BMD® / Monteban®140-919Bacitracin Methylene Disalicylate, HalofuginoneHydrobromideBMD® / Stenorol®140-926Bacitracin Methylene Disalicylate, Narasin,NicarbazinBMD® / Maxiban®140-937Bacitracin Methylene Disalicylate, MonensinSodiumBMD® / Coban®141-058Bacitracin Methylene Disalicylate, Roxarsone,Semduramicin Sodium3-Nitro® / Aviax™ / BMD®141-059Bacitracin Methylene Disalicylate,Chlortetracycline BMD® 10, 25, 30, 40, 50, 60, 75 / CTC® 50, 65, 70, BMD® 25, 30, 40, 50, 60, 75 / ChlorMax™®- 50, 60, 70, MICRO-CTC® 100141-065Bacitracin Methylene Disalicylate, SemduramicinSodiumAviax™ / BMD®141-085Bacitracin Methylene Disalicylate, Zoalene BMD® / Zoamix®141-088Bacitracin Methylene Disalicylate, Nitarsone BMD® / Histostat®141-097Bacitracin Methylene Disalicylate, Ivermectin BMD® / Ivomec® Premix for Swine141-100Bacitracin Methylene Disalicylate, Decoquinate,Roxarsone3-Nitro® / BMD® / Deccox®141-102Bacitracin Methylene Disalicylate, Decoquinate BMD® / Deccox®141-112Bacitracin Methylene Disalicylate, Narasin,Nicarbazin, Roxarsone3-Nitro® / BMD® / Maxiban®141-121Bacitracin Methylene Disalicylate, Roxarsone,Salinomycin Sodium3-Nitro® / Bio-Cox® / BMD®141-124Bacitracin Methylene Disalicylate, Narasin,NicarbazinBMD® / Maxiban®141-136Bacitracin Methylene Disalicylate, SalinomycinSodiumBio-Cox® / BMD®141-138Bacitracin Methylene Disalicylate, Monensin,Roxarsone3-Nitro® / BMD® / Coban®141-140Bacitracin Methylene Disalicylate, Monensin BMD® / Coban®141-142Amprolium, Bacitracin Methylene Disalicylate,Roxarsone3-Nitro® / Amprol® / BMD®141-144Bacitracin Methylene Disalicylate, Fenbendazole BMD® / Safe-Guard®141-153Bacitracin Methylene Disalicylate, Diclazuril BMD® / Clinacox™141-154Bacitracin Methylene Disalicylate, RobenidineHydrochlorideBMD® / Robenz®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 5 of 70Number141-155Bacitracin Methylene Disalicylate, RobenidineHydrochloride, Roxarsone3-Nitro® / BMD® / Robenz®141-156Amprolium, Bacitracin Methylene Disalicylate Amprol® / BMD®141-179Bacitracin Methylene Disalicylate, Lasalocid Avatec® / BMD®141-190Bacitracin Methylene Disalicylate, Diclazuril,Roxarsone3-Nitro® / BMD® / Clinacox™141-194Bacitracin Methylene Disalicylate, Diclazuril BMD® / Clincox®141-195Bacitracin Methylene Disalicylate, Diclazuril Clinacox™/ Flavomycin®141-279Nicarbazin, Bacitracin methylene disalicylate Nicarb® 25% plus BMD®200-081Bacitracin Methylene Disalicylate, Roxarsone,Salinomycin Sodium3-Nitro® / BMD® / Sacox®200-082Bacitracin Methylene Disalicylate, SalinomycinSodiumBMD® / Sacox®200-164Bacitracin Methylene Disalicylate, Nicarbazin BMD® / Nicarmix 25®200-242Bacitracin Methylene Disalicylate,Chlortetracycline Calcium Complex BMD®-25, -30, -40, -50, -60, or -75 / Aureomycin® -50, -70, -80, -90 or -100200-358Bacitracin Methylene Disalicylate,Chlortetracycline HydrochloridePennchlor/ BMD044-016Bacitracin Zinc, Clopidol, Roxarsone Coyden 25® with Roxarsone and Bacitracin Zinc045-348Bacitracin Zinc, Decoquinate Albac® / Deccox®, Broiler Finisher Medicated046-920Bacitracin Zinc Baciferm® - 10, Baciferm® - 25, Baciferm® - 40, Baciferm® -50047-933Bacitracin Zinc, Monensin, USP Coban® plus Baciferm®049-934Bacitracin Zinc, Clopidol Coyden 25® with Bacitracin Zinc065-015Bacitracin Zinc, Hydrocortisone Acetate,Neomycin Sulfate, Polymyxin B Sulfate Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment, Vetropolycin HC Ophthalmic Ointment065-016Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate Bac-Neo-Poly Ophthalmic Ointment, Vetropolycin Ophthalmic Ointment065-114Bacitracin Zinc, Neomycin Sulfate, Polymyxin BSulfateMycitracin® Sterile Ophthalmic Ointment065-313Bacitracin Zinc Baciferm® Soluble 50065-476Bacitracin Zinc, Hydrocortisone Acetate,Neomycin Sulfate, Polymyxin B SulfateCortisporin Veterinary Ophthalmic Ointment065-485Bacitracin Zinc, Neomycin Sulfate, Polymyxin BSulfateNeosporin Ophthalmic Ointment091-326Bacitracin Zinc, Decoquinate, Roxarsone3-Nitro® / Deccox® / Albac®096-933Bacitracin Zinc, Robenidine Hydrochloride Robenz® Plus Zn Bacitracin098-452Bacitracin Zinc Albac® 50 Type A Medicated Article105-758Amprolium, Bacitracin Zinc, Ethopabate,RoxarsoneAmprol HI-E® / Baciferm® / 3-Nitro®114-794Amprolium, Bacitracin Zinc, Ethopabate Baciferm® / Amprol HI-E® Premix123-154Bacitracin Zinc, Monensin Sodium, Roxarsone3-Nitro®-10 / Baciferm® / Coban® Premix126-052Bacitracin Zinc, Lasalocid, Roxarsone3-Nitro® / Avatec® / Baciferm®134-830Bacitracin Zinc, Monensin Sodium Albac® / Coban®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 6 of 70Number136-484Bacitracin Zinc, Carbarsone Baciferm® / Carb-O-Sep®137-536Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Bio-Cox®138-703Bacitracin Zinc, Monensin Sodium, Roxarsone3-Nitro® / Albac® / Coban®139-190Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Bio-Cox® / Baciferm®139-235Bacitracin Zinc, Salinomycin Sodium Baciferm® / Bio-Cox®140-865Bacitracin Zinc, Narasin Baciferm® / Albac®, Baciferm® / Monteban®141-083Bacitracin Zinc, Lasalocid Avatec® / Baciferm®141-109Bacitracin Zinc, Lasalocid Avatec® / Baciferm®141-146Bacitracin Zinc, Nicarbazin Nicarb® / Baciferm®141-181Bacitracin Zinc, Lasalocid Avatec® / Albac®200-086Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Sacox®200-089Bacitracin Zinc, Salinomycin Sodium Baciferm® / Sacox®200-143Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Baciferm® / Sacox®200-203Bacitracin Zinc, Carbarsone Albac® / Carb-O-Sep®200-204Bacitracin Zinc, Salinomycin Sodium Albac® / Bio-Cox®200-205Amprolium, Bacitracin Zinc, Ethopabate Albac® / Amprol Hi-E®200-206Bacitracin Zinc, Decoquinate, Roxarsone3-Nitro® / Albac® / Deccox®200-207Bacitracin Zinc, Clopidol, Roxarsone3-Nitro® / Albac® / Coyden 25®200-208Bacitracin Zinc, Lasalocid, Roxarsone Avatec® / 3-Nitro® / Albac®200-209Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Sacox®200-210Bacitracin Zinc, Salinomycin Sodium Albac® / Sacox®200-211Bacitracin Zinc, Monensin, Roxarsone3-Nitro® / Albac® / Coban®200-212Bacitracin Zinc, Robenidine Hydrochloride Albac® / Robenz®200-213Bacitracin Zinc, Decoquinate Albac® / Deccox®3-Nitro® / Albac® / Amprol Hi-E®200-214Amprolium, Bacitracin Zinc, Ethopabate,Roxarsone200-215Bacitracin Zinc, Roxarsone, Salinomycin Sodium3-Nitro® / Albac® / Bio-Cox®200-217Amprolium, Bacitracin Zinc, Ethopabate,3-Nitro® / Albac® / Amprol Hi-E®Roxarsone200-218Bacitracin Zinc, Clopidol Albac® / Coyden 25® / Albac®200-223Bacitracin Zinc Albac® 50 Type A Medicated Article031-555Balsam Peru Oil, Castor Oil, Trypsin Trypzyme® Aerosol039-583Balsam Peru Oil, Castor Oil, Trypsin Granulex Aerosol Spray044-759Bambermycins Flavomycin® 4095-543Amprolium, Bambermycins, Ethopabate Amprol HI-E® & Bambermycins, Amprol HI-E® / Flavomycin®3-Nitro® / Amprol HI-E® / Flavomycin®095-547Amprolium, Bambermycins, Ethopabate,Roxarsone095-548Amprolium, Bambermycins, Roxarsone3-Nitro® / Amprol / Flavomycin®3-Nitro® / Amprol / Flavomycin®095-549Amprolium, Bambermycins, Ethopabate,RoxarsoneFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 7 of 70Number098-340Bambermycins, Monensin Sodium Flavomycin® / Monensin098-341Bambermycins, Monensin, Roxarsone3-Nitro® / Coban® / Flavomycin®101-628Bambermycins, Roxarsone, Zoalene3-Nitro® / Flavomycin® / Zoalene101-629Bambermycins, Zoalene Flavomycin® / Zoalene112-687Bambermycins, Lasalocid, Roxarsone3-Nitro® / Avatec® / Flavomycin®130-185Amprolium, Bambermycins Flavomycin® / Amprolium130-661Bambermycins, Carbarsone Carb-O-Sep / Flavomycin®131-413Bambermycins Flavomycin® 0.4, Flavomycin® 2132-448Bambermycins Flavomycin®134-185Bambermycins, Roxarsone, Salinomycin Sodium3-Nitro® / Bio-Cox® / Flavomycin®134-284Bambermycins, Salinomycin Sodium Bio-Cox® / Flavomycin®137-483Bambermycins, Halofuginone Hydrobromide Flavomycin® / Stenorol®140-339Bambermycins, Nicarbazin Flavomycin®, Nicarb®140-843Bambermycins, Narasin, Roxarsone3-Nitro® / Flavomycin® / Monteban®140-845Bambermycins, Narasin Flavomycin® / Monteban®140-918Bambermycins, Halofuginone Hydrobromide Flavomycin® / Stenorol®140-942Bambermycins, Narasin, Nicarbazin Flavomycin® / Maxiban®141-034Bambermycins Gainpro® Type A Medicated Article141-129Bambermycins, Lasalocid Avatec® / Flavomycin®141-158Bambermycins, Diclazuril Clinacox™ / Flavomycin®200-080Bambermycins, Roxarsone, Salinomycin Sodium3-Nitro® / Flavomycin® / Sacox®200-080Bambermycins, Roxarsone, Salinomycin Sodium3-Nitro® / Flavomycin® / Sacox®200-083Bambermycins, Salinomycin Sodium Flavomycin® / Sacox®200-388Gentamicin Sulfate, Betamethason Valerate GB Topical Spray034-010Betamethasone Acetate, Betamethasone SodiumBetavet Soluspan SuspensionPhosphate034-267Betamethasone Acetate, Gentamicin Sulfate Gentocin® Durafilm Ophthalmic SolutionBetasone Aqueous Suspension049-185Betamethasone Dipropionate, BetamethasoneSodium Phosphate034-010Betamethasone Acetate, Betamethasone SodiumBetavet Soluspan SuspensionPhosphateBetasone Aqueous Suspension049-185Betamethasone Dipropionate, BetamethasoneSodium Phosphate046-821Betamethasone Valerate, Gentamicin Sulfate Gentocin® Otic Solution113-231Betamethasone Valerate, Gentamicin Sulfate Topagen® Ointment132-338Betamethasone Valerate, Gentamicin Sulfate Gentocin® Topical SprayOtomax®140-896Betamethasone Valerate, Clotrimazole,Gentamicin Sulfate200-183Betamethasone Valerate, Gentamicin Sulfate Gentavet® Otic Solution200-188Betamethasone Valerate, Gentamicin Sulfate Betagen™ Topical SprayFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 8 of 70NumberTri-Otic Ointment200-229Betamethasone Valerate, Clotrimazole,Gentamicin SulfateVetro-Max®200-283Betamethasone Valerate, Clotrimazole,Gentamicin SulfateGBC Ointment™200-287Betamethasone Valerate, Clotrimazole,Gentamicin Sulfate200-415Betamethasone Valerate, Gentamicin Sulfate Gentamicin Sulfate Topical Spray200-416Gentamicin sulfate and Betamethasone valerate Gentamicin Topical SprayAmforol® Suspension042-548Attapulgite, Bismuth Subcarbonate, KanamycinSulfate042-841Attapulgite, Bismuth Subcarbonate, KanamycinAmforol® Veterinary Oral TabletsSulfate034-705Boldenone Undecylenate Equipoise®140-872Bovine Somatotropin (Sometribove Zinc)Posilac 1 Step®035-016Bunamidine Hydrochloride Scolaban 400045-738Buquinolate, Lincomycin HydrochlorideLincomix® / Bonaid, Lincomycin & BuquinolateMonohydrate130-872Butacaine Sulfate, Nitrofurazone Nitrofurazone Anesthetic Dress.104-184Butamisole Hydrochloride Styquin132-533Butamisole Hydrochloride Styquin Parenteral 1.1%102-990Butorphanol Tartrate Torbutrol® Injection103-390Butorphanol Tartrate Torbutrol® Tablets135-780Butorphanol Tartrate Torbugesic®141-047Butorphanol Tartrate Torbugesic-SA®200-239Butorphanol Tartrate Dolorex®200-322Butorphanol Tartrate Butorphanol Tartrate Injection200-332Butorphanol Tartrate Butorphic™ Injection200-408Butorphanol Tartrate Butorphanol Tartrate Injection200-448Butorphanol Tartrate, Melengestrol Acetate,Heifermax® plus Optaflexx® and Rumensin®Monensin Sodium, Ractopamine Hydrochloride094-642Cambendazole Camvet Suspension Horse Wormer096-506Cambendazole Camvet Horse Wormer Pellets096-731Cambendazole Camvet Horse Wormer Paste 45%009-339Ammonium Chloride, Caramiphen Edisylate Carafen Cough Syrup, Carafen Cough Tablets041-061Carbadox Mecadox® Premix 10092-955Carbadox, Pyrantel Tartrate Banminth® / Mecadox®141-211Carbadox, Oxytetracycline Dihydrate Mecadox® 10 / Terramycin® 100, Mecadox® 10 / Terramycin®200, Mecadox® 10 / Terramycin® 50 039-646Bacitracin Methylene Disalicylate, Carbarsone Carb-O-Gain118-507Amprolium, Carbarsone Amprol® / Carb-O-Sep®130-661Bambermycins, Carbarsone Carb-O-Sep / Flavomycin®136-484Bacitracin Zinc, Carbarsone Baciferm® / Carb-O-Sep®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 9 of 70Number200-203Bacitracin Zinc, Carbarsone Albac® / Carb-O-Sep®038-879Carbarsone, Zoalene Carb-O-Sep® / Zoamix®038-879Carbarsone, Zoalene Carb-O-Sep® / Zoamix®032-946Carbomycin, Oxytetracycline Hydrochloride Magna Terramycin® Soluble Powder139-633Carfentanil Citrate Wildnil®139-879Carnidazole Carnidazole, Spartrix®141-053Carprofen Rimadyl® Caplets for Dogs141-111Carprofen Rimadyl® Chewable Tablets141-199Carprofen Rimadyl® Injectable200-366Carprofen Novocox Caplets200-397Carprofen Vetprofen™200-498Carprofen Carprieve™200-555Carprofen Librevia™031-555Balsam Peru Oil, Castor Oil, Trypsin Trypzyme® Aerosol039-583Balsam Peru Oil, Castor Oil, Trypsin Granulex Aerosol Spray119-688Cefadroxil Cefa-Tabs®140-684Cefadroxil Cefa-Drops®141-285Cefovecin sodium Convenia®141-232Cefpodoxime proxetil Simplicef®200-543Cefpodoxime proxetil Cefpodoxime Proxetil Tablets141-209Ceftiofur Crystalline Free Acid Excede™ Sterile Suspension141-235Ceftiofur Crystalline Free Acid Excede™ For Swine140-890Ceftiofur Hydrochloride Excenel Sterile Suspension, Excenel® RTU, Excenel® SterilePowder141-238Ceftiofur Hydrochloride Spectramast™ LC Sterile Suspension141-239Ceftiofur Hydrochloride Spectramast™ DC Sterile Suspension141-288Ceftiofur Hydrochloride Excenel® RTU EZ140-338Ceftiofur Sodium Naxcel® Sterile Powder200-420Ceftiofur Sodium Ceftiofur Sodium Sterile Powder200-421Ceftiofur sodium Ceftiofur for Injection141-326Cephalexin Rilexine® Chewable Tablets108-114Cephapirin Benzathine Cefa-Dri®, Tomorrow® Infusion097-222Cephapirin Sodium Cefa-Lak®, Today® Intramammary Infusion046-789Chloral Hydrate, Magnesium Sulfate, ChloropentPentobarbital055-002Chloramphenicol Tevcocin055-051Chloramphenicol Chloromycetin Tablets 100 mg, Chloromycetin Tablets 250 mg,Chloromycetin Tablets 500 mg055-059Chloramphenicol Viceton® Tablets065-137Chloramphenicol Amphicol-VFDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 10 of 70Number065-149Chloramphenicol Chloromycetin Ophthalmic Ointment065-150Chloramphenicol Chloramphenicol Capsules065-241Chloramphenicol Mychel-Vet Capsules (50 mg)065-460Chloramphenicol Chloramphenicol 1% Ophthalmic, Vetrocloricin OphthalmicOintment065-461Chloramphenicol Anacetin Tablets065-463Chloramphenicol Mychel-Vet Injection065-489Chloramphenicol Mychel-Vet Tabs065-491Chloramphenicol Medichol Tablets055-047Chloramphenicol Palmitate Chloromycetin Palmitate Oral Suspension009-782Chlorhexidine Acetate Nolvasan® Antiseptic Ointment200-301Chlorhexidine Acetate Privasan™ Antiseptic Ointment009-809Chlorhexidine Hydrochloride Nolvasan® Cap-Tabs®010-434Chlorhexidine Hydrochloride Nolvasan® Suspension006-983Chlorobutanol, Doxylamine Succinate A-H Injection141-245Chloroquine Phosphate, Embutramid, Lidocaine Tributame™ Euthanasia Solution011-678Chlorothiazide Diuril® Tablet012-734Chlorothiazide Diuril®038-160Chlorphenesin Carbamate Maolate® Tablets, Maolate® Veterinary048-761Chlortetracycline Aureomycin® 100 Granular, Aureomycin® 50 Granular,Aureomycin® 90 Granular, Aureomycin® 90 Meal138-935Chlortetracycline Pennchlor™ 100MR, Pennchlor™ 50, Pennchlor™ 50-G,Pennchlor™ 90, Pennchlor™ 90-G, Pennchlor™ 100-G,Pennchlor™ 100 Hi-Flo141-059Bacitracin Methylene Disalicylate,Chlortetracycline BMD® 10, 25, 30, 40, 50, 60, 75 / CTC® 50, 65, 70, BMD® 25, 30, 40, 50, 60, 75 / ChlorMax™®- 50, 60, 70, MICRO-CTC® 100141-147Chlortetracycline, Decoquinate Chloromax® / Deccox®141-185Chlortetracycline, Decoquinate Aureomycin® / Deccox®141-201Chlortetracycline, Laidlomycin PropionatePotassiumAureomycin® / Cattlyst®141-250Chlortetracycline, Lasalocid Aureomycin® and Bovatec®200-259Chlortetracycline, Roxarsone, SalinomycinSodium3-Nitro® / ChlorMax™ / Sacox®200-260Chlortetracycline, Roxarsone, SalinomycinSodium3-Nitro® / Bio-Cox® / ChlorMax™200-261Chlortetracycline, Salinomycin Sodium Bio-Cox® / ChlorMax™200-262Chlortetracycline, Salinomycin Sodium ChlorMax™ / Sacox®200-263Chlortetracycline, Monensin Sodium ChlorMax™ / Coban®200-314Chlortetracycline, Sulfamethazine Pennchlor S®200-355Chlortetracycline, Roxarsone, SalinomycinSodiumPennchlor™ / Bio-Cox® / 3-Nitro®FDA APPROVED PRODUCTS January 2014Section 2.0 - Active Ingredients Page 11 of 70。
4,4-二氨基二苯醚(ODA)101-80-4的质量标准
4,4-二氨基二苯醚(ODA)101-80-4的质量标准
4,4'-二氨基二苯醚(ODA)
4,4′-Diaminodiphenyl ether
Cas 号:【101-80-4】M D L:MFCD00007863
分子式:C12H12N2O; O(C6H4NH2)2分子量:200.24
4,4'-二氨基二苯醚98%500g453元
性状:近白色结晶。微溶于水,稍溶于乙醇。低毒,半数致死量(大鼠,经口)725mg/kg。有致癌可能性。有刺激性。
熔点:190-192℃
闪点:218℃
质量标准:观Appearance 灰白色粉末
红外光谱鉴别Infrared spectrometry 和对照品匹配
纯度Purity ≥98% (GC)
熔点Melting point 190°C - 194°C
乙醇溶解试验solubility in ethanol 合格
贮存:密封保存。
香料。染料中间体。树脂合成。
别名:4,4′-二氨基苯醚, 4,4-双(氨基苯基)醚,二氨基苯醚,4,4′-二氨基二苯醚 4-Aminophenyl ether 4,4′-Oxydianiline 4,4’-Bis(aminophenyl)ether
分子结构式:
订货信息:
4,4'-二氨基二苯醚98%100g98元
4,4'-二氨基二苯醚分析标准品250mg490元
摩尔实验室超纯水器
摩尔实验室超纯水器Molecular Lab Water Purifier使用说明书Owner ManualsΣH2O上海摩勒生物科技有限公司Molecular Instrument Shanghai Co,LtdEMAIL:customercare@本说明书适用于摩尔纯水器和超纯水器系列。
在纯水器和超纯水器的安装和使用上存在差别,请在安装和使用时注意对应的安装、使用、维护说明。
纯水器系列包括分析型、普及型、学生型、生化型、经济型。
超纯水器系列包括元素型、细胞型、基因型、原子型。
本说明书主要用于帮助用户能够正确使用和维护本公司的“摩尔Molecular”设备,保证设备处于最佳运行状态,并延长使用寿命,基于科学的态度,请用户使用“摩尔”设备前,认真阅读本使用说明书。
按您购买的型号安装和操作。
特别提示:超纯水现取现用,请不要用普通塑料桶装很长的时间,请一定接受超纯水现取现用的观念。
请节约使用超纯水。
超纯水的造水成本高。
请在普通实验和清洗器具时使用III级纯水,而不要用大量的超纯水做清洗等工作。
超纯水仪器是精密仪器,请在下班前关断电源和自来水水源。
同时请加强安全管理。
目录1 设备基本原理简介4 2摩尔(超)纯水器工作条件6 3设备控制与安全设计和功能键说明6 4纯水器设备安装步骤85 纯水器初次调试步骤146 摩尔MOLRESEARCH 分析型超纯水器操作维护标准程序16 7摩尔MOLGENERAL普及型纯水器操作维护标准程序17 8摩尔MOLUNIV 学生型纯水器操作维护标准程序18 9摩尔MOLBIOCHEM 生化型纯水器操作维护程序19 10摩尔MOLRO 经济型纯水器操作维护标准程序2011 超纯水器设备安装步骤2112 超纯水器初次调试步骤27 13摩尔MOLELEMENT元素型超纯水器操作维护标准程序29 14摩尔MOLCELL 细胞型超纯水器操作维护标准程序30 15摩尔MOLGENE基因型超纯水器操作维护标准程序31 16摩尔MOLATOM 原子型超纯水器操作维护标准程序32 17 系统维护方法33 18台式机耗材更换操作步骤34 19落地式机器耗材更换操作步骤36 20非故障现象解答38 21常见故障现象诊断和处理39 22摩尔纯水器出厂质量检查报告40 23摩尔纯水器装箱单41 25摩尔纯水器客户验收单43 26 摩尔产品保修卡44 27意见反馈表46 28附录:超纯水基本知识471 设备基本原理简介PP纤维滤芯:独特的外松内紧结构,能有效去除水源中的5micron以上的悬浮物、泥沙、颗粒杂质;高效活性碳滤芯:具有极强的吸附过滤性能,有效去除蒸馏水中的异色、异味、有机物等杂质。
医学知识一全国各类蛋白仪分解
拜耳DCA2000+干式糖化血红蛋白仪
测试项目:糖化血红蛋白及微量蛋白, 更符合现今有效治理糖尿病的国际指 引 采用随机尿液样本, 7 分钟取得结果, 方便快捷 简易操控,机体精巧,特为病房内使 用而设计 即用试剂盒,不需稀释或预备程序 条形码校对程序,不用另购昂贵对液 萤幕显示讯息丰富,包括操作指示, 校对状态,测试讯息及结果等 可贮存 16 组病人结果
全定量特种蛋白金标检测仪[小旋风]
产地:挪威 型号:TYX10 HbAlc(糖化血红蛋白) U—Albumin(尿微量白蛋白) CRP(C—反应蛋白) D-Dimer(D—二聚体)
TD-III
Nephstar TM
检测原理:乳胶增强免疫散射比浊法 测试模式:磁卡模式,将同批号试剂标准曲线存入磁卡内,测试时不用 作标准曲线,只需刷卡输入标准曲线。仪器自动扣除本底干扰,不用作 空白对照 操作模式:半自动,只须加入样品和试剂,其余由仪器自动完成;中文 界面,操作简单 测试速度:15~180秒/测试 检测性质:全定量 检测试剂:NephstarTM特定蛋白分析仪专用试剂 质 控 液:附赠 采用标准:IFCC CRM470国际标准 样 本 量:10 L~40 L,全血、血清、尿液 附送附件:稀释模式芬兰原装进口电子移液器
全自动特定蛋白分析仪
❖ 贝克曼 Array 360 ❖ 贝克曼 ICS-II ❖ 西门子(原德灵)BNP/BN ❖ 法国赛诺菲QM300 特定蛋白 ❖ 雅培AXSYM 免疫分析仪 ❖ 雅培IMX 免疫分析仪
贝克曼ARRAY360特定蛋白分析仪
测定原理:速率散射比浊法( 特种蛋白)、散射比浊抑制法 ( 药物) 测定速度:80个结果/小时 温度控制:26.7 C± 1 C 吸液量:7-20uL 试剂消耗:每测试47uL血清 定标有效期:特定蛋白一次
免疫组化辅助试剂.
品名
规格
价格
备注
C0301
山羊抗兔IgG(H+L)/FITC
0.1ml
190
绿色荧光
C0302
山羊抗小鼠IgG(H+L)/FITC
0.1ml
190
绿色荧光
C0303
兔抗山羊IgG(H+L)/FITC
0.1ml
190
绿色荧光
C0304
兔抗大鼠IgG(H+L)/FITC
0.1ml
190
绿色荧光
C0305
0.1ml
190
进口分装
C0253
兔抗山羊IgG(H+L)/Biotin
0.1ml
190
进口分装
C0254
山羊抗大鼠IgG(H+L)/Biotin
0.1ml
190
进口分装
*-以上二抗的工作浓度如下(可提供2ml包装产品):
1:20,000 - 1:400,000 for ELISA and Western blotting using enzyme-conjugated streptavidin
160
MZ013
AEC
Ameresco
1g
50
MZ014
BCIP/NBT
Roche
100mg
350
MZ015
苏木素
Ameresco
10g
300
MZ016
伊红
Ameresco
10g
140
MZ017
吉姆萨
Ameresco
10ml
150
MZ018
甲基绿
Ameresco
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
2.
3.
4.
5.
Defense against infection (e.g., antibodies)
Covalent disulfide bonds between the sulfhydryl groups of Cys residues stabilize folded structures of many proteins
Zinc fingers
Contain repeats of cysteine & histidine • Bind zinc ions • Fold into looped structures
Proteins
Primary functional molecules of the cell; execute the tasks directed by the genetic material
1.
Structural molecules (e.g., hair, fingernails, connective tissue)
Sheet (ribbons)
Models of -sheet 2.20
Turn
Reverses the direction of the chain
X
Pro
Gly
Tertiary Structure
3D arrangements of secondary structure Folding is result of interactions between side chains of a.a. that lie in different regions of the primary sequence Domains: basic units of tertiary structure
2.
3.
4.
Protein Structure
Determines function Folding is defined by 2 parameters
1.
2.
Properties of R-groups
Bond angles about Ca
Folded shape is called conformation
Helix-loop-helix 6.27
•Contain DNA-binding domains formed by dimerization of two polypeptide chains
•Dimerization domains are each formed by two helical regions separated by a loop
3D folding stabilized by disulfides For secreted proteins (mostly) Covalent linkage between cysteines
Important structures in transcription factors
Helix-turn-helix
•One helix makes most of the contacts with DNA, while the other helices lie across the complex to stabilize the interaction.
QuaternHale Waihona Puke ry Structure 2.21
3D arrangement of subunits (different polypeptide chains interacting together) Example: Hemoglobin 4 Subunits Arrangement controls O2 affinity
Special Importance of Some A.A.
1.
Glycine: provides the most flexibility to backbone bond rotation Histidine: complexes with inorganics such as zinc & iron; can be uncharged or (+) charged, therefore involved in ion exchange reactions Proline: only a.a. that is 2ndary amine, severely constrains peptide bond, will break alpha-helical structure Cysteine: thiol groups is most chemically reactive modification of all a.a. in protein, complexes with inorganics such as zinc & iron
Basic & Acidic Amino Acids 2.14
Lysine & Arginine are very positively charged in the cell (hydrophilic) Histidine can be uncharged or positively charged (involved in ion exchange)
Protein Folding
Folding controlled by weak forces Fully folded called native state Unfolded called denatured state
Covalent (disulfide) Bonds 2.16
1. H atom 2. Amino group (NH3+) 3. Carboxyl group (COO-)
4. R group (side chain)
R-group (Side Chain)
R -group determines identity, function
A.A. are categorize by chemical properties of the side chains
Enzymes (catalyze nearly all biochemical reactions)
Amino acids 2.13
20 different amino acids in proteins
Chemical properties of side chains determine function Central carbon atom (Ca)
Uncharged and Polar Amino Acids 2.14
Hydroxyl groups
Amide groups
Polar side chains can form H bonds with water; therefore, are hydrophilic & tend to be located on the outside of proteins
Four Levels of Structure
1) Primary
sequence of amino acids
2) Secondary
regular repeating local structures
3) Tertiary
3D folding
4) Quaternary
3D arrangement of subunits
“Flexibility” at Ca
Peptide bond configuration
The peptide bond nearly always has the trans configuration since it is more favorable than cis, which is sometimes found to occur with proline residues
Defines amino (N) terminus and carboxy (C) terminus
Peptide Bond Resonance
Bond between the carbonyl carbon and the nitrogen has a partial double bond character; therefore, rotation around this bond is restricted
Secondary Structures
Two main types: a helix sheet
Two minor types: Random coil turn
a helix
Regular right handed helix 3.6 amino acids per turn Regular H-bonding (backbone) R groups displayed to exterior Many are amphipathic
Independently folded Often function independently Proteins built in „modules‟ that are strung together